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ABSTRACT 
 
 
Since their discovery in the Buszek laboratories in 2007, the indole arynes and their 
cycloaddition chemistry has demonstrated its significance in achieving the total synthesis of 
biologically active indole alkaloid natural products such as the trikentrins and herbindoles in 
a facile manner. The application of 6,7-indole aryne cycloaddition methodology towards the 
total synthesis of (±)-cis-trikentrin B, one of the representative members of the trikentrin 
family of natural products is described.  
The 5,6,7-tribromoindole served as the 6,7-indole aryne precursor which was 
synthesized via an adapted Leimgruber-Batcho synthetic protocol. The success with 
achieving annulation at the 6,7-position of the indole nucleus in (±)-cis-trikentrin B relied 
heavily on one crucial question i.e., whether the key intermediate 5,6,7-tribromo-N-TBS-
indole would undergo selective metal-halogen exchange at C-7. Gratifyingly the indole 
underwent selective metal-halogen exchange at C-7 and subsequent elimination to give 
exclusively the 6,7-indole aryne which underwent Diels-Alder cycloaddition with 
 iv 
 
cyclopentadiene. To complete the synthesis, the remaining unreacted C-5 bromo position was 
subjected to Stille cross-coupling to install the trans-butenyl side chain at this site. 
 The original regiochemical observations in 6,7-indole aryne cycloadditions werewere 
made with N-Me-4-phenyl-6,7-dibromoindole resulting predominantly in the contrasteric 
regiosiomer .This phenomenon was observed by the virtue of the polarized nature of the 6,7-
indole aryne as revealed by computational studies involving ab initio calculations.  
In order to probe further into the regioselective cycloadditions of 6,7-indole arynes, a 
series of 6,7-dibromoindoles were synthesized to investigate the effect of 2-, 3-, 4- and 5-
substitution on the regioselectivity of 6,7-indole aryne cycloadditions with 2-tert-butylfuran. 
The results of this investigation indicated that the degree of polarization of the 6,7-indole 
aryne bond depends on electronic nature and the positions of the various substituents on the 
pyrrole and benzene rings of the indole which in turn is responsible for imparting 
regioselectivity in the 6,7-indole aryne cycloadditions. 
The Buszek laboratories have previously demonstrated the exclusive generation of 
6,7-indole arynes from 4,6,7- and 5,6,7-tribromoindoles via a remarkable selective metal-
halogen exchange at C-7 for use in natural products total synthesis and library development. 
In connection to these previous efforts, synthesis of the 4,5,6- and 4,5,7-tribromoindoles, the 
remaining two members of the tribromoindole series, is described. Treatment with n-BuLi 
followed by quenching with various electrophiles reveals a strong preference for initial 
metal-halogen exchange at the C-7 position in the case of 4,5,7-tribromoindoles, and at the 
C-4 position in the case of the 4,5,6-tribromoindole scaffold. Exclusive generation of the 4,5-
indole aryne in either system followed by cycloaddition with 2-tert-butylfuran shows only a 
modest regiochemical preference in the cycloadducts. Finally, the 4,5-benzannulated 
 v 
 
scaffolds were subjected to Negishi cross-coupling with dimethyl and diethylzinc to 
demonstrate the proof-of-concept for library development. 
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CHAPTER 1  
INTRODUCTION AND BACKGROUND 
1.1 Arynes and Hetarynes: Discovery and Significance 
Arynes and hetarynes (aka heteroarynes) have emerged as versatile and effective tools 
in organic synthesis for the construction of complex natural products of biological importance 
and for the design and development of novel architecturally unique scaffolds for drug 
discovery (Gampe and Carreira, 2012; Tadross and Stoltz, 2012; Goetz, Shah et al., 2014). 
The prototypical aryne is benzyne itself, 1.11 (Roberts, Simmons et al., 1953). Hetarynes are 
arynes that are derived from heteroaromatic systems, most commonly those in which a 
heteroatom such as nitrogen, oxygen or sulfur is a part of the aromatic nucleus.  The area of 
aryne and hetaryne chemistry has certainly come a long way since the discovery of benzyne in 
1953, where a myriad of novel hetarynes have been discovered and reported. This 
comprehensive list of hetarynes that have been reported in the literature include 2,3-pyridyne, 
1.12 (Martens and den Hertog, 1962); 3,4-pyridyne, 1.13 (Kauffman and Boettcher, 1962); 
2,3-thiophyne (Reinecke, Newsom et al., 1981); 1.14, 3,4-thiophyne, 1.15 (Reinecke, 
Newsom et al., 1981), 1-Boc-3,4-pyryne, 1.16 (Liu, Chan et al., 1999); 2,3-quinolyne, 1.17 
(Fleet and Fleming, 1969); 3,4-quinolyne, 1.18 and 5,6-quinolyne, 1.19 (Kauffman, Fischer et 
al., 1967); 7,8-quinolyne, 1.20 (Collis and Burrell, 2005); 1,2-didehydrobenzothiophene, 1.21 
(Reinecke, Newsom et al., 1981); 1,2-carbazolyne, 1.22 (Brown, Choi et al., 1997); 5,6-
carbazolyne, 1.23 (Goetz, Silberstein et al., 2014); 4,5-indolyne, 1.24, 5,6-indolyne, 1.25 and 
6,7-indolyne, 1.26 (Buszek, Luo et al., 2007); 4,5-didehydrobenzofuran, 1.27, 5,6-
didehydrobenzofuran, 1.28 and 6,7-didehydrobenzofuran, 1.29 (Brown and Buszek, 2012).  
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Figure 1.1. Arynes and hetarynes shown in their common triple bond canonical 
representation. 
 
Although numerous aforementioned novel hetarynes have been discovered since 
1953, the related published reports reveal that most of these reactive intermediates were 
studied for their structure and reactivity rather than their applications. It was only in the last 
two decades that there has been a resurgence in the area of aryne and hetaryne chemistry 
where these intermediate species have been extensively used in the total synthesis of several 
important natural products. Some of the recent examples include the usage of benzyne as 
demonstrated by Stoltz in the total synthesis of the tetrahydroisoquinoline alkaloid, (-)-
quinocarcin, 1.30 (Allan and Stoltz, 2008) and in the synthesis of (-)-curvularin, 1.31, a 
naturally occurring benzannulated macrolactone (Tadross, Virgil et al., 2010). The 3,4-
pyridyne cycloaddition methodology was instrumental in the concise syntheses of naturally 
occurring alkaloids such as (s)-macrostomine, 1.32 (Enamorado, Ondachi et al., 2010) and 
ellipticine, 1.34 (Diaz, Cobas et al., 2001). Intermolecular nucleophilic additions to the 4,5-
indole arynes have been successfully utilized in the total syntheses of the members of the 
welwitindolinone family of natural products such as N-methylwelwitindolinone C 
isothiocyanate, 1.35 (Quasdorf, Huters et al., 2011), N-methylwelwitindolinone D isonitrile, 
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1.36 (Styduhar, Huters et al., 2013) and (-)-N-methylwewitindolinone B isothiocyanate, 1.37 
(Weires, Styduhar et al., 2014). Similarly, (+)-tubingensin A, 1.38, a carbazole-containing 
alkaloid was readily accessed via intramolecular carbazolyne cyclization strategy (Goetz, 
Silberstein et al., 2014). Finally, the advantages of the 6,7-indole aryne chemistry in 
particular have been successfully exploited by the Buszek laboratories for the total synthesis 
of the trikentrins, 1.39-1.40 (Buszek, Brown et al., 2009; Chandrasoma, Brown et al., 2013) 
and the herbindoles, 1.41-1.42 (Buszek, Brown et al., 2009). 
  
 
Figure 1.2. Examples of natural products that used the aryne and hetaryne methodologies in 
their total synthesis. 
 
1.2 Indole Arynes and their Cycloaddition Chemistry 
Arynes derived from all the benzenoid positions of the ubiquitous indole nucleus 
namely, the 4,5-, 5,6 and the 6,7-indole aryne (Figure 1.3), were not know until their 
discovery in the Buszek laboratories in 2007. The Buszek laboratories developed and 
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reported the first ever general approach for the generation of the three isomeric indole arynes 
via facile metal-halogen exchange and elimination of the corresponding o-dibromoindoles 
(Scheme 1.1).  
 
         Figure 1.3. The three isomeric indole arynes. 
 
 
Scheme 1.1. Generation of 4,5-, 5,6- and 6,7-indole arynes and trapping with furan. 
The 6,7-indole aryne cycloaddition chemistry soon culminated in the successful total 
syntheses of (±)-cis-trikentrin A and (±)-herbindole A, two representative members of a rare 
class of benzannulated indole alkaloid natural products namely, the trikentrins and the 
herbindoles. In 1986, Capon and co-workers isolated the members of the trikentrin family of 
natural products namely, (+)-cis-trikentrin A, (+)-cis-trikentrin B, (+)-trans-trikentrin A, (-)-
trans-trikentrin B and iso-trans-trikentrin B from the marine sponge Trikentrion 
flabelliforme, collected off of the Australian coast in Darwin (Capon, Macleod et al., 1986). 
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These newly discovered compounds were found to exhibit growth inhibitory activity towards 
gram-positive bacteria, Bacillus subtilis but, no activity levels were provided. 
The structurally related herbindoles were isolated four years later in 1990 by Scheuer 
and co-workers from the Australian sponge Axinella sp. (Herb, Carroll et al., 1990). Similar 
to the trikentrins, the members of this family namely, herbindole A, herbindole B and 
herbindole C were also found to possess potent biological significance i.e. cytotoxicity 
against KB cells as well as fish antifeedant properties.  
In the first generation synthesis of (±)-cis-trikentrin A, the N-TBS-4-ethyl-6,7-
dibromoindole, 1.55 was subjected to the metal-halogen exchange and elimination protocol 
to generate the 4-ethyl-6,7-indole aryne, 1.56 (Scheme 1.2). The reactive aryne intermediate 
underwent a [4 + 2] cycloaddition reaction with cyclopentadiene to yield the cycloadduct, 
1.57 thus, achieving annulation at the 6,7-position of the indole nucleus eventually leading to 
the target molecule, 1.59 (Buszek, Brown et al., 2009).  
 
Scheme 1.2. First generation total synthesis of (±)-cis-trikentrin A  
 6 
 
In a similar manner, the 6,7-indole aryne cycloaddition methodology was exploited 
by the Buszek laboratories towards the total synthesis of (±)-herbindole A, 1.67 (Buszek, 
Brown et al., 2009) (Scheme 1.3). 
 
Scheme 1.3. First generation total synthesis of (±)-herbindole A. 
Subsequently, the Buszek laboratories reported the second-generation total synthesis 
of (±)-cis-trikentrin A which involved the use of N-TBS-4,6,7-tribromoindole, 1.68 as the 
6,7-indole aryne precursor (Brown, Luo et al., 2009).  
 
Scheme 1.4. Second generation total synthesis of (±)-cis-trikentrin A 
Treatment of 1.68 with a slight excess of n-BuLi at -78 °C induced a selective metal-
halogen exchange at C-7 to yield the 7-lithiated intermediate, 1.69 (Scheme 1.4). 
Subsequently, warming up the reaction mixture to -40 to -30 °C resulted in an elimination of 
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LiBr to generate exclusively the 6,7-indole aryne, 1.70 which was further trapped with 
cyclopentadiene to afford 4-bromo-6,7-benzannulated scaffold 1.71. The unreacted C-4 
bromine was subjected to Negishi cross-coupling protocol with Et2Zn to install the desired 
ethyl substituent at the 4-position thus, providing the late-stage intermediate, 1.72.  
Indeed, the 6,7-indole aryne, 1.73 has proved to be an extremely powerful and 
versatile intermediate in the total synthesis of biologically active, complex natural products 
such as the trikentrins, 1.76-1.77 and the herbindoles, 1.74; 1.75; and 1.78 (Figure 1.4). The 
6,7-annulation in each of these target molecules was readily accessed via facile 6,7-indole 
aryne generation and its subsequent cycloaddition reaction with cyclopentadiene thus, 
demonstrating the first successful applications of the intermolecular 6,7-indole aryne 
cycloaddition methodology in total synthesis.   
 
 
Figure 1.4. 6,7-benzannulated indole alkaloid natural products. 
The 6,7-indole aryne cycloaddition methodology has also demonstrated its 
significance in the development of small molecule libraries of biological relevance. Recently, 
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the Buszek laboratories constructed an unprecedented 93-membered library of polycyclic, 4-
substituted-6,7-benzannulated indoles structurally inspired from the trikentrins and 
herbindoles (Thorton, Brown et al., 2011). The 6,7-indole aryne precursor, 1.79 was 
subjected to selective metal-halogen exchange at C-7 to produce the 7-lithiated intermediate, 
1.80 (Scheme 1.5). Subsequently, elimination of LiBr resulted in the generation of the 4-
bromo-6,7-indole aryne, 1.81 which was further trapped with furan and cyclopentadiene to 
afford the corresponding 6,7-cycloadducts, 1.82a and 1.82b. The strained olefin in the 
cycloadduct was reduced with diimide prior to subjecting the remaining unreacted 4-bromo 
position to a series of Pd-catalyzed cross-coupling reactions with a collection of boronic 
acids and secondary amines to yield a suite of 4-substituted-6,7-benzannulated indole library 
members structurally represented by 1.83 and 1.84. The reduction step was necessary as it 
was found that the presence of this strained alkene resulted in significantly reduced cross-
coupled yields.  
 
Scheme 1.5. Examples of diverse library construction using a 6,7-indole aryne cycloaddition 
and cross-coupling tactic. 
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The newly synthesized benzannulated indole scaffolds were found to exhibit anti-
proliferative activities at micromolar and sub-micromolar concentrations in the L1210 
leukemia and HL-60 promyelocytic leukemia cell based assays (Perchellet, Waters et al., 
2012). The proposed mechanism of action of these library members in L1210 leukemia cell 
lines was apoptotic DNA degradation and nuclear fragmentation. Furthermore, in a 
subsequent HL-60 cell based study these compounds inhibited the proliferation of tumor cells 
through microtubule de-stabilization, a mode of action that resembles that of an established 
anti-cancer drug, vincristine (Perchellet, Waters et al., 2014). Additionally, the annulated 
indoles mimicked the effect of jasplakinolide by remarkably increasing the rate and level of 
actin polymerization, suggesting that they might also stabilize the cleavage furrow to block 
cytokinesis. Apparently, the annulated indoles interact with both tubulin to decrease 
microtubule assembly and with actin to block cytokinesis, thereby inducing bi- and multi-
nucleation resulting in genomic instability and apoptosis. The compelling biological results 
obtained in the cell-based assays helped to validate the significance of 6,7-indole aryne 
chemistry in library development and drug discovery. 
During the course of our investigations into the cycloadditions reactions of indole 
arynes, we observed a remarkable regioselectivity preference in the 6,7-indole aryne 
cycloadditions with 2-substituted furans (Brown, Luo et al., 2009). For example, when the 
6,7-indole aryne generated from N-methyl-3-phenyl-6,7-dibromoindole was trapped with 2-
tert-butylfuran, the contrasteric (more sterically crowded) regioisomer was formed about 50 
folds excess over the non-contrasteric regioisomer. By contrast, no such regiochemical 
preference was observed in the case of 4,5- and 5,6-indole aryne cycloadditions, where the 
two regioisomers were obtained in a 1:1 ratio (Scheme 1.6). 
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Scheme 1.6. Regioselectivity in 4,5-, 5,6- and 6,7-indole aryne cycloadditions with 2-tert-
butylfuran. 
 
These observations were rationalized on the basis of ab initio DFT methods 
performed by the Buszek laboratories in collaboration with the Cramer research group at the 
University of Minnesota (Garr, Luo et al., 2009). Technically, the 6,7-indole aryne can be 
represented either as a cummulene, 1.85; an alkyne, 1.86 or alternatively, as a polarized 
structure, 1.87. The computational studies revealed that the polarized form of the 6,7-indole 
aryne is the major resonance contributor possessing an electrophilic site at C-6 and a 
nucleophilic site at C-7 thus, existing as a zwitterionic structure (Figure 1.5). 
 
Figure 1.5. Polarized nature of the 6,7-indole aryne. 
 11 
 
The regioselectivity of 6,7-indole aryne cycloadditions was further explored by 
trapping the 6,7-indole aryne with a series of 2-substituted furans (Table 1). 
 
Table 1. Regioselective 6,7-indolyne cycloadditions with 2-substituted furans. 
entry R A B Yield, % 
1 Me 80 20 89 
2 Et 84 16 90 
3 i-Pr 94 6 88 
4 t-Bu 98 2 91 
5 Ph >99 <1 92 
6 SO2Ph <1 >99 83 
 
In this study, it was observed that as the electron density at the 2-position of the furan 
increases, the regiochemical preference favoring the contrasteric regioisomer, 1.89 increases 
as well. This effect is exactly reversed in the presence of an electron-withdrawing group such 
as phenylsulfonyl at the 2-position of the furan where none of the contrasteric regioisomer 
was obtained.  
The putative mechanism governing these fascinating reaction profiles is shown in 
Figure 1.6. In presence of an electron-donating group at the 2-position of the furan, the 
canonical form of furan, 1.92 is the major resonance contributor thus resulting in the 
formation of the contrasteric regioisomer, 1.93 as the predominant product. On the other 
hand, in the presence of an electron-withdrawing group at the 2-position of the furan, the 
canonical form of furan, 1.95 is the major resonance contributor thus, affording the non-
contrasteric regioisomer, 1.96 as the major product. Thus, dipolar effects can induce 
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regioselection with asymmetrically substituted dienes when polarization of the benzyne triple 
bond imparts substantial asynchronous electrophilic substitution character to the initial bond 
forming step. 
 
Figure 1.6. Putative mechanism for the 6,7-indole aryne cycloadditions with 2-substituted 
furans. 
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CHAPTER 2 
APPLICATION OF 6,7-INDOLE ARYNE CYCLOADDITION METHODOLOGHY IN 
TOTAL SYNTHESIS OF (±)-cis-TRIKENTRIN B 
 
2.1 Retrosynthetic Analysis of (±)-cis-trikentrin B 
 Encouraged by the versatile synthetic utility of 4,5,6-tribromoindole towards the 
second-generation total synthesis of (±)-cis-trikentrin A and furthermore in the construction 
of structurally-related libraries of biological significance, we envisioned that a similar 
strategy involving a novel tribromoindole scaffold could be adapted to achieve the total 
synthesis of yet another representative member of the trikentrin family namely, (±)-cis-
trikentrin B.  (±)-cis-trikentrin A and (±)-cis-trikentrin B share a common structural feature 
i.e., the cis-1,3-dimethyl-cyclopentenoid ring at the 6,7-position of the indole nucleus 
however, differ only in the substitution pattern at the other positions on the benzene ring. (±)-
cis-trikentrin A possesses an ethyl substituent at the C-4 position whereas (±)-cis-trikentrin B 
bears a trans-butenyl side chain at the C-5 position of the indole system. Hence, we devised a 
rational retrosynthetic scheme for (±)-cis-trikentrin B that paralleled the total synthesis of 
(±)-cis-trikentrin A (Scheme 2.1).  
 We envisioned that the trans-butenyl side chain at the C-5 position could be installed 
by subjecting the aryl-bromide bond in 2.10 to Pd-catalyzed Stille cross-coupling reaction. 
The cis-1,3-dimethyl-cyclopentanoid motif in 2.10 could be achieved by converting the 
primary alcohols in 2.11 to their corresponding mesylates followed Fujimoto reduction 
protocol. The primary alcohols in turn, could result via a series of transformations on the 
olefin bond of the 6,7-cycloadduct in 2.12. These include, cis-dihydroxylation followed by 
oxidative cleavage of the diols to the corresponding dialdehydes and eventually, the 
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reduction of the dialdehydes to the primary alcohols. The 6,7-cycloadduct, 2.12 could be 
obtained by trapping the 5-bromo-6,7-indole aryne in a [4 + 2] cycloaddition reaction with 
cyclopentadiene. 2.13 could be generated via a selective and exclusive metal-halogen 
exchange at the C-7 bromine of the 5,6,7-tribromoindole scaffold to give 2.14 followed by 
elimination of LiBr to generate exclusively the 6,7-indole aryne.  The 6,7-indole aryne 
precursor 2.15 could be obtained via Bartoli indole synthesis starting from 1,2,3-tribromo-4-
nitrobenzene to yield 5,6,7-tribromoindole followed by silyl protection of the indole nitrogen. 
Nitration of 1,2,3-tribromobenzene, 2.17 could yield the Bartoli precursor, 2.16 and finally, 
2.17 could result from diazotization and further bromination of 2,6-dibromoaniline, 2.18.  
 
Scheme 2.1. Retrosynthetic analysis of (±)-cis-trikentrin B 
  The success of our synthetic approach relied heavily on one most crucial question i.e., 
will 2.15 undergo a selective metal-halogen exchange at C-7 and on subsequent elimination, 
result in the generation of exclusively the 6,7-indole aryne, 2.13 which can be further trapped 
with cyclopentadiene to achieve the desired 6,7-annulation? It was of intrinsic importance to 
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address this issue since the occurrence of metal-halogen exchange at any positions other than 
C-7 would result in undesired outcomes.  
 
 
Scheme 2.2. Potential sites for metal-halogen exchange in 5,6,7-tribromoindole and the 
corresponding arynes. 
  
 For example, if metal-halogen exchange occurred at the 5-bromo position then it 
would result in the 5-lithio-6,7-dibromoindole intermediate, 2.20 which upon elimination 
would generate the undesired 5,6-indole aryne, 2.21 (Scheme 2.2). Similarly, occurrence of 
metal-halogen exchange at C-6 would result in the formation of 6-lithiated intermediate, 2.22 
and subsequently generate either the 5,6-indole aryne, 2.21 or the desired 6,7-indole aryne, 
2.23 or alternatively, the mixture of both thus, complicating matters. Ideally, it was desirable 
to induce metal-halogen exchange selectively and exclusively at C-7 to provide 2.24 in order 
to generate the 5-bromo-6,7-indole aryne as the sole intermediate for further cycloaddition 
reaction with cyclopentadiene as planned in the retrosynthetic scheme. 
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2.2 Synthesis of 5,6,7-Tribromoindole  
 
 With the issue of selective metal-halogen exchange in sight, our initial efforts were 
directed towards designing practical, scalable synthetic routes for the desired 6,7-indole 
aryne precursor namely, the 5,6,7-tribromoindole. Previously, the Buszek research group had 
already experienced success with the Bartoli reaction in the synthesis of 4,6,7-tribromoindole 
which served as the 6,7-indole aryne precursor in the second-generation total synthesis of  
(±)-cis-trikentrin A and more recently, a versatile scaffold for the construction of 6,7-
benzannulated-4-substituted indole libraries of biological importance. Hence, the logical first 
step was to adapt the Bartoli synthetic protocol (Bartoli, Palmieri et al., 2005) to access the 
desired 5,6,7-tribromoindole (Scheme 2.3). 
 
 
Scheme 2.3. Bartoli synthetic route to 5,6,7-tribromoindole. 
 Thus, starting from commercially available 2,6,-dibromoaniline, 2.18 was subjected 
to diazotization with tBuONO followed by bromination with CuBr2 in MeCN at 60 °C to 
afford 1,2,3-tribromobenzene, 2.17 in 80% yield. Subsequent nitration of 2.17 was achieved 
with fuming nitric acid to provide in 82%, 2,3,4-tribromonitrobenzene, 2.16 which served as 
the precursor to the Bartoli synthetic step. 2.16 was treated with vinylmagnesium bromide 
under typical Bartoli reaction conditions (-40 °C, THF, 1 h) to yield the desired 5,6,7-
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tribromoindole, 2.25 in 32%. Although we could successfully synthesize the desired 
tribromoindole scaffold, despite several attempts to enhance the yield of the Bartoli step, it 
never rose above 32%. This prompted us to explore alternate synthetic routes that would 
enable us to obtain the 5,6,7-tribromindole is much improved yields. Consequently, we 
turned our attention to yet another well-known indole forming reaction namely, the 
Leimgruber-Batcho indole synthesis (Batcho and Leimgruber, 1985).  
 
 
Scheme 2.4. Leimgruber-Batcho synthesis of 5,6,7-tribromoindole 
 Commercially available and very inexpensive ($ 0.029/1g), p-toluidine 2.26 was 
brominated in situ (HBr, 3.0 eq.; H2O2, 2.0 eq.; MeOH) to quantitatively yield 2.27 which 
was subjected to diazotization and subsequent bromination protocol as described earlier to 
afford 3,4,5-tribromotoluene 2.28 in 80% yield (Scheme 2.4). Nitration of 2.28 was achieved 
with fuming nitric acid in 89% to provide the Leimgruber-Batcho precursor 2.29. Treatment 
of 2.29 with tri(piperidin-1-yl)methane (1.5 eq.) at 105 °C under vacuum (105 torr) for 3 h 
resulted in the enamine intermediate 2.30 which could be isolated however, we chose to carry 
it forward as it is in the subsequent step which involved FeCl3·6H2O-catalyzed reductive 
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cyclization in the presence of NH2NH2·H2O to afford the desired 5,6,7-tribromoindole in 
61% yield over 2 steps, a much better improvement over the Bartoli reaction.  
2.3 Selective Metal-Halogen Exchange and Cycloaddition 
 With the required 5,6,7-tribromoindole in hand, we were back to addressing the issue 
of inducing a selective metal-halogen exchange at the C-7 position of this scaffold.  
 
 
Scheme 2.5. Selective metal-halogen exchange and quenching in N-Me-5,6,7-
tribromoindole. 
  
 The tribromoindole, 2.25 was N-alkylated by treatment with MeI (2.0 eq) and NaH 
(2.0 eq) in THF to obtain N-Me-5,6,7-tribromoindole 2.31 in 86% yield. To our delight, 
when 2.31 was treated with a slight excess of n-BuLi at -78 °C in PhMe, the metal-halogen 
exchange occurred selectively and exclusively at the C-7 site to provide the 7-lithiated 
intermediate 2.32 which upon quenching with water at low temperature installed a proton at 
the same position to yield N-Me-5,6-dibromoindole 2.33 (Scheme 2.5). The formation of 
2.33 as the sole product of this reaction provided evidence for the occurrence of selective and 
exclusive metal-halogen exchange at the C-7 site of the N-Me-5,6,7-tribromoindole scaffold 
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which was extremely essential for the generation of the desired 6,7-indole aryne in the 
subsequent steps of the synthetic scheme. 
 With the issue of selective metal-halogen exchange addressed, we next attempted to 
generate the desired 6,7-indole aryne in 2.31 and trap the resulting aryne with 
cyclopentadiene to achieve annulation at the 6,7-position of the indole nucleus. Thus, 2.31 
was subjected to a facile and selective metal-halogen exchange protocol by treatment with n-
BuLi in PhMe at -78 °C. Warming up the reaction mixture to -40 to -30 °C resulted in the 
elimination of LiBr to generate N-Me-5-bromo-6,7-indole aryne which readily underwent a 
Diels-Alder [4 + 2] cycloaddition reaction with cyclopentadiene to provide the 6,7-
cycloadduct, 2.35 in 72% yield (Scheme 2.6). Notably, no metal-halogen exchange 
whatsoever was observed at the 5-bromo position thus, the C-5 Ar-Br bond remaining 
completely unaffected and now available for performing cross-coupling chemistry as 
proposed in the original retrosynthetic strategy.   
 
Scheme 2.6. Exclusive 6,7-indole aryne generation and trapping in N-Me-5,6,7-
tribromoindole. 
 
Although N-Me-5,6,7-tribromindole served as an appropriate template for 
investigating the site of regioselective metal-halogen exchange, this scaffold by itself was not 
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quite suitable to proceed towards the final target molecule. According to our synthetic 
strategy, we required a protecting group that could be readily installed and removed in the 
final stages of the synthesis. One such protecting group that we believed would work was the 
tert-butyldimethyl silyl (TBS) group since it was previously employed by the Buszek 
laboratories in the total synthesis of cis-trikentrin A and herbindole A. Initially we attempted 
the conventional conditions to protect the indole nitrogen as its TBS ether. Thus, the 5,6,7-
tribromoindole was reacted with TBS-Cl (2.0 eq.) in the presence of NaH in THF at 0 °C. 
These efforts did not result in successful installation of the protecting group. However 
changing from TBSCl to TBSOTf (3.0 eq.) in the presence of NaH (4.0 eq.) and Et3N (2.0 
eq.) in THF at 0 °C, provided the desired N-TBS-5,6,7-tribromindole, 2.15 consistently in 
78% yield (Scheme 2.7). Gratifyingly, similar to the N-Me-5,6,7-tribromoindole, when N-
TBS-5,6,7-tribromoindole was subjected to metal-halogen exchange and elimination 
protocol, it resulted in a selective and exclusive lithium-bromine exchange at the C-7 site and 
eventually generating the 6,7-indole aryne which was trapped with cyclopentadiene to obtain 
the desired 6,7-benzannulated intermediate 2.12 in 83% yield.  
 
 
Scheme 2.7. 6,7-indole aryne generation and trapping in N-TBS-5,6,7-tribromoindole. 
 
With the required cycloadduct, 2.12 in hand, we turned our attention towards 
transforming this cyclopentadiene adduct into the cis-1,3-dimethylcyclopentanoid ring at the 
6,7-position. Our initial efforts involved a protocol that was identical to the one previously 
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employed by our group in the total synthesis of (±)-cis-trikentrin A and (±)-herbindole A 
(Scheme 2.8). 2.12 was subjected to cis-dihydroxylation (OsO4, 0.1 eq.; NMO, 5.0 eq.; 
THF/H2O, 1.5:1) to afford the diol intermediate 2.36. Subsequently, the diols were 
oxidatively cleaved NaIO4 (15 eq.; THF/H2O, 3.3:1) to provide the 1,3-cis-dialdehyde 2.37 in 
almost quantitative (99%) yield. Treatment of 2.37 with excess of ethanethiol converted the 
dialdehydes into their corresponding bisdithioacetals 2.38 and resulted in the deprotection of 
the indole nitrogen in the same step. Our initial attempts to execute hydrogenolysis of the C-
S bond of  the bisdithioacetal in order to install the methyl groups with Raney nickel (grade 
2800, Aldrich) in refluxing ethanol, as was done in our previous synthesis of racemic cis-
trikentrin A, only gave 2.40 as the major product. Changing the solvent to acetone gave a 
mixture of the desired 5-bromoindole 2.39 in only 16-31% yield, accompanied by varying 
amounts of the fully reduced undesired indole 2.40. 
 
 
Scheme 2.8. Installation of 1,3-cis -dimethyl-cyclopentanoid ring via Raney Ni reduction. 
These complications in accessing 2.39, prompted us to investigate an alternate route 
namely, the Fujimoto reduction protocol since Kerr and co-workers had recently shown that 
similar results could be obtained employing the aforementioned synthetic procedure 
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(Jackson, Banfield et al., 2005). Thus, the late stage intermediate 2.37 was reduced with 
NaBH4, (30 eq., THF, 0 °C) to obtain the primary diols 2.11 (86%), which were further 
mesylated with MsCl (2.2 eq., Et3N, 4.0 eq.; CH2Cl2) to afford the bismesylate 2.41 in 82% 
yield (Scheme 2.9). The Fujimoto reduction (NaI, 15 eq.; Zn dust, 60 eq.; glyme, 90 °C) was 
carried out in a sealed tube to provide the 1,3-cis-dimethyl-cyclopentanoid 2.10 in 58% yield. 
Desilylation (TBAF, 2.0 eq.; THF) afforded the desired 5-bromoindole 2.39 in 82% yield 
with the C-5 bromine still intact (Scheme 2.9).  
 
Scheme 2.9. Fujimoto reduction protocol. 
The final step of the synthesis involved subjecting the bromine at the C-5 position to 
Pd-catalyzed Stille cross-coupling reaction with vinyl tin reagent 2.42 to install the trans-
butenyl side chain in the final target molecule. Our initial attempts using conventional Stille 
cross-coupling conditions failed to give the desired result. However, changing the ligand 
from triphenylphosphine to triphenylarsine and employing microwave heating readily 
afforded (±)-cis-trikentrin B in 73% yield thus completing the total synthesis of this natural 
product (Scheme 3.0) 
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Scheme 3.0. Stille cross-coupling at the C-5 position.  
In conclusion, we have successfully achieved the total synthesis of (±)-cis-trikentrin 
B using intermolecular cycloaddition of the 6,7-indole aryne with cyclopentadiene coupled 
with Pd-catalyzed Stille cross-coupling reaction.  Finally, this project clearly highlights the 
following advantages of 6,7-indole aryne cycloaddition methodology in natural products total 
synthesis: 
 Facile generation of the indole aryne from readily available o-dibromides 
 Mild reaction conditions (-78 °C to rt) 
 High yielding, clean reactions 
 Scalable (50+ g scale) 
 Adaptable to other benzannulated indole natural products 
 Adaptable to library synthesis 
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CHAPTER 3 
INVESTIGATIONS INTO THE EFFECT OF VARIOUS SUBSTITUTION PATTERNS 
ON THE REGIOSELECTIVITY OF 6,7-INDOLE ARYNE CYCLOADDITIONS WITH 2-
SUBSTITUTED FURANS 
 
3.1 Preliminary 6,7-Indole Aryne Regioselectivity Studies 
 As mentioned in Chapter 1, during the course of our investigations into the 
cycloaddition reactions of indole arynes, we observed a remarkable regioselectivity 
preference in the [4 + 2] Diels-Alder cycloaddition reactions of 6,7-indole arynes with 2-
substituted furans. The original regiochemical observations were made with N-Me-3-phenyl-
6,7-dibromoindole where it was found that the aryne generated from this precursor upon 
trapping with 2-tert-butylfuran resulted in the formation of the contrasteric or more sterically 
crowded regoisomer about 50 folds excess over the non-contrasteric regioisomer. On the 
other hand, under identical reaction conditions, no such regiochemical preference was 
observed in the 4,5- and 5,6-indole aryne cycloadditions with 2-tert-butylfuran where the two 
regioisomers were formed in a 1:1 ratio (Scheme 3.1)  
 Scheme 3.1. Regioselectivity in 6,7-indole aryne cycloadditions with 2-tert-butylfuran 
 25 
 
 In order to investigate the fundamental electronic and steric parameters that account 
for these fascinating reaction profiles, the Buszek laboratories performed ab initio 
calculations using DFT methods in collaboration with the Cramer group at the University of 
Minnesota. These computational studies revealed that the exceptional regioselectivity 
observed with the 6,7-indole arynes is by the virtue of the polarized nature of this 
intermediate species. The 6,7-indole aryne can be more appropriately viewed as a 
zwitterionic species, possessing an electrophilic site at C-6 and a nucleophilic site at C-7 
(Figure 3.1).    
 
Figure 3.1. Polarized nature of the 6,7-indole aryne 
The regioselectivity of 6,7-indole aryne cycloadditions was further explored by 
trapping the 6,7-indole aryne with a series of 2-substituted furans (Table 3.1). 
 
Table 3.1. Regioselective 6,7-indolyne cycloadditions with 2-substituted furans. 
entry R A B Yield, % 
1 Me 80 20 89 
2 Et 84 16 90 
3 i-Pr 94 6 88 
4 t-Bu 98 2 91 
5 Ph >99 <1 92 
6 SO2Ph <1 >99 83 
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In this study, it was observed that as the electron density at the 2-position of the furan 
increases, the regiochemical preference favoring the contrasteric regioisomer, A increases as 
well. This effect is exactly reversed in the presence of an electron-withdrawing group such as 
phenylsulfonyl at the 2-position of the furan where none of the contrasteric regioisomer was 
obtained.  
 Intrigued by these results, we were prompted to embark on an empirical study to 
investigate the effect of various substituents at different positions of the indole system on the 
regioselectivity of 6,7-indole aryne cycloadditions with 2-tert-butylfuran. Thus, a collection 
of 2-,3-,4-, and 5-substituted-6,7-dibromoindole precursors were synthesized using adapted 
Bartoli, Fischer and Leimgruber-Batcho protocols.  
3.2 Synthesis of 2- and 3-substituted-6,7-dibromoindoles 
 2,3-dibromophenylhydrazine hydrochloride 3.11 was treated with a collection of 
aldehydes and ketones 3.12 under Fischer conditions (EtOH, 100 °C, 3 h) to yield a series of 
2- and 3-substituted-6,7-dibromoindoles 3.13 a-g. The newly synthesized indoles were N-
methylated with MeI (2.0 eq.) in presence of NaH (2.0 eq.) to afford the desired 2- and 3-
substituted-6,7-indole aryne precursors 3.14 a-g in excellent yields (Scheme 3.2). 
 Scheme 3.2. Fischer synthesis of 2- and 3-substituted-6,7-dibromoindoles 
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3.3 Synthesis of 4-substituted-6,7-dibromoindoles 
 The Bartoli indole synthesis was employed to access 6,7-dibromoindoles possessing 
various halogens at the 4-position of the indole system. For example, commercially available 
4-fluoroaniline 3.15a was nitrated with fuming nitric acid to give the 4-fluoro-2-nitroaniline 
3.16a in 89% yield. This was brominated in situ with HBr and H2O2 to afford 3.17a (89%) 
which was subsequently diazotized and brominated to yield 1,2-dibromo-5-fluoro-3-
nitrobenzene 3.18a. Bartoli indole reaction with CH2=CHMgBr (3.5 eq.) in THF at -78 °C 
gave the 6,7-dibromo-4-fluoro-1H-indole 3.19a (31%). N-alkylation was achieved with MeI 
(NaH, THF, 0 °C) to give the 6,7-dibromo-4-fluoro-1-methyl-1H-indole 3.20a in 77% yield. 
Similarly, Bartoli protocol was implemented to synthesize 4-iodo-, 4-bromo- and 4-ethyl-6,7-
dibromoindole precursors 3.20b-d. 
 
 Scheme 3.3. Bartoli synthesis of 4-substituted-6,7-dibromoindoles. 
  
 In order to synthesize 4- and 5-substituted-6,7-dibromoindoles bearing substitution at 
the C-3 site, Fischer indole synthesis was used (Scheme 3.4). 
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Scheme 3.4. Fischer synthesis of 4- and 5-substituted-6,7-dibromoindoles with substitution 
at C-3 
 
The tribromonitrobenzene 3.21.a was subjected to iron catalyzed reduction (activated 
carbon, NH2NH2•H2O, MeOH) to give the corresponding aniline 3.22.a (83%) which was 
subsequently converted to the hydrazine salt 3.23.a (6M HCl, NaNO2, SnCl2•2H2O, conc. 
HCl). Reaction of hydrazine salt with phenyl acetaldehyde (EtOH, 100 °C, seal tube) gave 
the 3-phenyl-4,6,7-tribromoindole 3.24.a in 67% yield which was N-alkylated as before with 
MeI. The 3-phenyl-5,6,7-trimbromoindole 3.24.b was synthesized following a similar 
sequence of reactions. 
With the required 6,7-dibromoindole precursors in hand, each of them were subjected 
to metal-halogen exchange and elimination protocol to generate the corresponding 6,7-indole 
arynes in these systems which were subsequently trapped with 2-tert-butylfuran to afford the 
cycloadducts in a specific regiochemical distribution, details of which are described in the 
following section. 
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3.4 Regioselective 6,7-Indole Aryne Cycloadditions 
We first examined the effect of substituted aryl and other groups at the 3-position of 
the indole on the regioselectivity of the 6,7-indole aryne cycloadditions (Table 3.2). 
 
Table 3.2. Regioselective 3-Substituted 6,7-Indole Aryne Cycloadditions with 2-tert-
Butylfuran 
 
entry R 3.27 3.28 Yield, % 
1 Ph 49 1 91 
2 4-MeOPh >99 <1 76 
3 4-F-Ph 15.7 1 59 
4 CH2Ph 10 1 58 
5 Et 6.1 1 64 
6 H 3.0 1 60 
 
It can be seen that a highly electron-rich 4-methoxyphenyl substituent (Table 3.2, 
entry 2) gave within our limits of detection and analysis, exclusively the contrasteric 
regioisomer 3.27. None of the alternate regioisomer 3.28 was obtained. This was a significant 
increase over the 3-phenyl substituent where the regioisomeric ratio was 49:1 in favor of 
3.27. On the other hand, the less electron-rich 4-fluorophenyl case exhibited somewhat lower 
degree of regiocontrol where the ratio dropped to 15:1 (Table 3.2, entry 3). There clearly 
appears to be a definitive trend over here i.e., as the electron density at the 3-position of the 
indole decreases from 4-methoxyphenyl to phenyl to 4-fluorophenyl, the regioselectivity in 
these cycloadditions decrease as well.  
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We next examined the issue of aromatic conjugation at the C-3 site and its effect on 
the regioselectivity. Thus, by breaking the conjugation at this site i.e., by incorporating a 
benzyl substituent, there was a significant diminution of regiocontrol, the regioisomeric ratio 
being 10:1 as compared to 49:1 in presence of a conjugated aromatic phenyl group at this 
position. This data point clearly suggests that the presence of conjugation at the C-3 site 
favors the contrasteric regioisomer to a significant degree. Furthermore, a simple alkyl group 
such as an ethyl group at this site resulted in further diminished yet a significant degree of 
regiocontrol (6.1:1).  It is evident from the data in entries 1-5 that the presence of any 
substitution at the C-3 position of the indole is beneficial for the regiochemistry of the 6,7-
indole aryne cycloadditions with 2-substituted furans. It is the total electron density at this 
site either due to conjugative or inductive effects that is responsible for imparting the 
regioselectivity. This point is further strengthen by the data in entry 6 where there is no 
substituent present at the C-3 position (R = H). In this case, we observed the lowest 
proportion of the contrasteric regioisomer (3:1).  
Subsequently, we turned our attention to the effect of aromatic conjugation at the 
other position on the pyrrole ring i.e., the C-2 site (Table 3.3). In this case, we observed a 
significant diminution of regiocontrol where the ratio dropped to 9.1:1 as compared to 49:1 
in presence of the same phenyl substituent at the C-3 position, this was a five times decrease 
in the regioselectivity. Interestingly, incorporating two aromatic conjugated phenyl groups at 
C-2 and C-3 resulted in further diminished selectivity with the distribution of 6.7:1. of the 
indole that is responsible for same site. This observation could be rationalized on the basis of 
the assumption that the steric hindrance between the two phenyl rings at the adjacent 
positions on the pyrrole ring prevents effective conjugation at this site and thus, reduces the 
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effect of conjugation on the regioselectivity. Also, the phenyl ring at the 2-position is almost 
certainly in a non-planar orientation by virtue of which its electronic contributions are more 
likely to be inductive rather than conjugative. However, even in these cases, the 
regioselectivity observed was much better than having no substituents present at either C-2 
and C-3 (Table 3.3, entry 4).   
 
 
Table 3.3. Regioselective 2-Phenyl- and 2,3-Diphenyl-6,7-indole Aryne 
Cycloadditions with 2-tert-Butylfuran 
 
entry R1  R2    3.30      3.31 Yield, % 
1 Ph H   49      1    91 
2 H Ph   9.1      1    61 
3 Ph Ph   6.7      1    62 
4 H H    3      1    60 
 
After examining the effect of various substituents on the pyrrole side of the indole, 
we turned our attention towards investigating the impact of different substitution patterns on 
the benzene ring. The effect of a halogen such as Br at the C-4 position on the 
regioselectivity was initially gauged. In this case, the regioselectivity ratio was 3.4:1 in favor 
of the contrasteric regioisomer (Table 3.4, entry 1). This regiochemical outcome was almost 
similar to the one obtained in case of no substitution at the C-3 site (3:1). Incorporating an 
aromatic conjugated phenyl group at this site resulted in a slight enhancement of 
regioselectivity ratio to 4.6:1 (Table 3.4, entry 2). This indicates that in this case, aromatic 
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conjugation at the C-3 site does impart some beneficial effect to the regioselectivity of these 
cycloaddition reactions.  
 
Table 3.4. Regioselective 4-Bromo- and 3-Phenyl-4-bromo-6,7-indole Aryne Cycloadditions 
with 2-tert-Butylfuran 
 
entry R1 R2 3.33 3.34 Yield, % 
1 Br H 3.4 1 76 
2 Br Ph 4.6 1 76 
 
However, a much more dramatic effect was observed when bromine was adjacent to 
the site of the 6,7-indole aryne i.e., at C-5 (Table 3.5) 
 
 
Table 3.5. Regioselective 5-Bromo- and 3-Phenyl-5-bromo-6,7-indole Aryne   
Cycloadditions with 2-tert-Butylfuran 
 
entry R1 R2 3.36 3.37 Yield, % 
1 H Br 1.4 1 68 
2 Ph Br 1.4 1 62 
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In this case, there was virtually no regioselectivity observed with the two 
regioisomers formed in a 1.4:1 ratio (Table 3.5, entry 1). Even the installation of a 
supposedly beneficial aromatic conjugation at the C-3 site did alter the regiochemical 
outcome with the isomers still obtained in an identical ratio (1.4:1). 
Finally, a collection of 6,7-dibromoindoles possessing halogens and other substituents 
at the 4-position were synthesized to study the effect of these groups on the regioselectivity 
of 6,7-indole aryne cycloadditions with 2-tert-butylfuran (Table 3.6). 
 
 
Table 3.6. Regioselective 4-Substituted 6,7-Indole Aryne Cycloadditions with 
2-tert-Butylfuran 
 
entry R 3.39 3.40 Yield, % 
1 F 2.3 1 71 
2 Br 3.4 1 76 
3 I 15.7 1 65 
4 Et 11.5 1 63 
 
It can be seen that a fluorine substituent at the C-4 position gave a regioselectivity 
ratio of 2.3:1 in favor of the contrasteric regioisomer as compared to 3.4:1 in case of a 
bromine at the same site. Furthermore, the presence of iodine at this position resulted in a 
significant enhancement in the regioselectivity with the distribution being 15.7:1. Thus, there 
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appears to be a definitive trend over here i.e., as the electronegativity at the 4-position of the 
indole decreases from fluorine to bromine to iodine, the regioselectivity in these 
cycloaddition reactions increase. Finally, an inductively electron-donating alkyl substituent 
such as an ethyl group at this site also provided a significant degree of regiocontrol (11.5:1).  
In conclusion, the experimental data reveal that different substituents affect the 
degree of polarization of 6,7-indole aryne bond which in turn controls the degree of 
regioselectivity. The presence of electron donating (e.g., p-OMe) conjugated phenyl 
substituents at the C-3 site provides the greatest degree of regiocontrol. The introduction of 
non-conjugated substituents at C-3 exhibits diminished but still significant regioselectivity 
thus suggesting that the presence of any electron rich group at this site benefits the 
regiochemistry in 2-substituted furan cycloadditions. The regioselectivity is significantly 
suppressed in the presence of a conjugated phenyl group at C-2 (9.1:1) as compared to 
having the same substituent at the C-3 site of the indole nucleus (49:1). Phenyl substitution at 
both C-2 and C-3 results in further diminution of regiocontrol (6.7:1), possibly due to the 
absence of a planar conformer. However, in these cases, the overall effect on regioselectivity 
is better than having no substitution at both sites (3:1). Substitution on the benzene side of 
the indole system results in most cases in a markedly reduced selectivity. The presence of C-
4 Br exhibits higher regiocontrol (3.4:1) as compared to virtually no selectivity in case of C-5 
Br (1.4:1). Phenyl conjugation at C-3 slightly enhances the regioselectivity in the C-4 Br case 
(4.6:1); however, it has no impact on the regiochemical distribution in case of a C-5 Br. As 
the electronegativity decreases from F to I at the C-4 site, the regioselectivity increases (e.g., 
F, 2.3:1; Br, 3.4:1; I, 15.7:1) in those cases where a C-3 phenyl substituent is absent. Finally, 
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the inductively electron-rich ethyl group also displays a significant degree of regiocontrol 
even without a C-3 phenyl substituent (11.5:1). 
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CHAPTER 4 
TRIBROMOINDOLES AS VERSATILE SYNTHETIC INTERMEDIATES FOR 
REGIOSELECTIVE METAL-HALOGEN EXCHANGE, INDOLE ARYNE FORMATION, 
AND FURTHER REACTIONS: SYNTHESIS AND REACTIONS OF 4,5,6- AND 4,5,7-
TRIBROMOINDOLES. 
 
4.1 Background: Tribromoindoles as versatile intermediates for Natural Products Total 
Synthesis and Library Development 
 
The Buszek research group has previously demonstrated the synthetic utility of two 
tribromoindoles namely, the 4,6,7- and the 5,6,7-tribromoindole in the total synthesis of 
biologically active, complex indole alkaloid natural products such as the trikentrins and the 
herbindoles and furthermore, in the construction of libraries of biological significance 
inspired from these natural products.  
 
Scheme 4.1. The second-generation total synthesis of (±)-cis-trikentrin A. 
For example, the 4,6,7-tribromoindole was shown to undergo a selective metal-
halogen exchange at C-7 and subsequent elimination to generate exclusively the 6,7-indole 
aryne. The remaining unreacted C-4 bromine readily underwent Pd(0)-catalyzed Negishi 
cross-coupling to complete the total synthesis of (±)-cis-trikentrin A (Scheme 4.1). 
Furthermore, the 4,6,7-tribromindole served as a versatile template for the 
construction of an unprecedented 93-membered library of polycyclic, benzannulated indoles 
exhibiting provocative biological activities (Scheme 4.2) 
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 Scheme 4.2. The 4,6,7-tribromoindole as a versatile scaffold for library synthesis. 
Similarly, the 5,6,7-tribromoindole resulted in exclusively the 6,7-indole aryne via a 
highly regioselective metal-halogen exchange at C-7 followed by elimination. Subsequently, 
the C-5 bromo position was subjected to Stille cross-coupling protocol to successfully 
achieve the total synthesis of (±)-cis-trikentrin B (Scheme 4.3). 
 
Scheme 4.3. The total synthesis of (±)-cis-trikentrin B. 
 Thus, it can be seen that both the 4,6,7- and 5,6,7-tribromoindoles were found to 
undergo a highly selective and exclusive metal-halogen exchange at C-7 to subsequently 
generate solely the 6,7-indole aryne intermediate upon elimination. None of the other bromo 
positions i.e., the C-4 and C-6 sites in the 4,6,7-tribromoindole were affected by n-BuLi. 
 38 
 
Likewise, the 5- and 6-bromo positions in the 5,6,7-tribromoindole scaffold remained 
unreacted on treatment with n-BuLi. 
 
4.2 The Tetrad of Tribromoindoles 
 
In connection with our ongoing total synthesis and indole library programs, and in 
order to better understand the proclivity for selective metal-halogen exchange in related 
polybromoindole systems, we decided to synthesize the remaining two members of the 
tribromoindole family, namely, 4,5,6- and 4,5,7-tribromoindoles (Figure 4.1), both of which 
were unknown in the literature. With these compounds in hand, we could examine the metal-
halogen exchange in these cases, as well as study the regioselective [4+2] cycloaddition 
behavior of the indole arynes produced in this manner. 
 
Figure 4.1. The members of the tribromoindole family. 
 Investigating the issue of metal-halogen exchange in these novel tribromoindole 
scaffolds was of intrinsic importance because the site of metal-halogen exchange would 
dictate the position of aryne formation in these systems. 
 For example, if metal-halogen exchange in the 4,5,6-tribromoindole scaffold occurred 
at the 4-bromo position then it would result in the 4-lithio-5,6-dibromoindole intermediate, 
4.12 which upon elimination would generate the 6-bromo-4,5-indole aryne, 4.13 (Scheme 
4.4). Similarly, occurrence of metal-halogen exchange at C-5 would result in the formation of 
5-lithiated intermediate, 4.14 and subsequently generate either the 4,5-indole aryne, 4.13 or 
 39 
 
the 5,6-indole aryne, 4.15 or alternatively, the mixture of both. Finally, in event of a metal-
halogen exchange at the C-6 bromine, the 4-bromo-5,6,-indole aryne, 4.15 would be obtained 
as the sole aryne. 
 
 
Scheme 4.4. The potential sites of metal-halogen exchange in 4,5,6-tribromoindole. 
 Likewise, in case of a metal-halogen exchange at the C-4 site in 4,5,7-tribromoindole, 
4.18 would be obtained which upon elimination would result in the formation of 7-bromo-
4,5-indole aryne, 4.19 (Scheme 4.5). The same aryne intermediate will result from a metal-
halogen exchange at the 6-bromo position. However, if the bromine at C-7 exchanges with n-
BuLi then it would not result in the generation of any indole aryne and unfortunately, under 
such circumstances, the 4,5,7-tribromoindole would fail to serve as a substrate for indole 
aryne generation. 
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Scheme 4.5. The potential sites of metal-halogen exchange in 4,5,7-tribromoindole. 
 
4.3 Synthesis of 4,5,6- and 4,5,7-Tribromoindoles 
The synthesis of 4,5,6-tribromoindole commenced with commercially available and 
inexpensive 3-methylaniline (m-toluidine), which was first acetylated (Ac2O, 1.0 eq.; 1,2-
DCE, 84 °C, 1 h) in 94% yield (Scheme 4.6). Nitration (conc. H2SO4, conc. HNO3, 0 °C, 1 h, 
75%), followed by amide hydrolysis (conc. HCl, glyme, 85 °C, 3 h, 84%) proceeded 
uneventfully and afforded 3-methyl-4-nitroaniline. In situ bromination (HBr, 3.0 eq.; 30% 
H2O2, 2.0 eq.; MeOH, rt, 12 h) gave 2,6-dibromo-3-methyl-4-nitroaniline in 91% yield. This 
aniline was subjected to diazotization and bromination (CuBr2, 1.3 eq.; tBuONO, 1.6 eq.; 
CH3CN, 60 °C, 1 h), providing the 3,4,5-tribromo-2-methylnitrobenzene indole precursor in 
77% yield. Subjecting this intermediate to the one-pot Leimgruber-Batcho indole conditions 
(tripiperidinylmethane, 1.5 eq., 105 °C, 15 torr, 3 h; then, FeCl3•6H2O, 0.065 eq.; activated 
carbon, 3.3 eq.; H2NNH2•H2O, 3.95 eq., 52% for two steps) gave the desired 4,5,6-
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tribromoindole in seven steps from m-toluidine. The indole was methylated (NaH, 3.0 eq.; 
then CH3I, 3.0 eq., THF, 0 °C) in 92% yield and 4.30 used in our subsequent studies. 
 
Scheme 4.6. Synthesis of 4,5,7-tribromoindole via Leimgruber-Batcho protocol. 
In a similar manner, the 4,5,7-tribromoindole was also prepared via the Leimgruber-
Batcho route (Scheme 4.7). Thus 2-methyl-3-nitroaniline was initially brominated as 
described above (91%), diazotized and further brominated (78%), and then converted to the 
desired indole 4.29 in only three steps (56%, one-pot, two steps). Methylation as before 
(94%) provided the compound 4.30 needed for our study. 
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Scheme 4.7. Synthesis of 4,5,7-tribromoindole via Leimgruber-Batcho protocol. 
 
4.4 Metal-Halogen Exchange Studies in N-Me-4,5,6- and 4,5,7-Tribromoindoles 
With the required tribromoindoles in hand, we first examined the site of metal-
halogen exchange in these systems. When N-Me-4,5,6-tribromoindole was treated with n-
BuLi at -78 °C, the metal-halogen exchange occurred selectively and exclusively at the C-4 
site (Scheme 4.8). The other bromo positions i.e., the C-5 and C-6 sites remained unaffected 
with n-BuLi. The evidence for the metal-halogen exchange at C-4 was obtained by 
quenching the 4-lithiated intermediate with water at low temperatures to provide N-Me-5,6-
dibromoindole in 62% yield. 
 
Scheme 4.8. Selective metal-halogen exchange in N-Me-4,5,6-tribromoindole. 
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However, when N-Me-4,5,7-tribromoindole on treatment with n-BuLi at -78 °C in 
PhMe did not exhibit exclusive metal-halogen exchange at a single site. In this case, it was 
observed that the C-7 bromine has a 4 times greater propensity than the bromine at the C-4 
site to exchange with n-BuLi (Scheme 4.9).  
 
Scheme 4.9. Metal-halogen exchange studies in N-Me-4,5,7-tribromoindole. 
Consequently, on quenching the lithiated intermediates with water at low 
temperatures, N-Me-4,5-dibromoindole and N-Me-5,7-dibromoindole were obtained in a 4:1 
ratio. This data suggests that N-Me-4,5,7-tribromoindole may not be a very useful substrate 
for indole aryne generation since the C-7 bromo site is more susceptible to metal-halogen 
exchange as compared to the C-4 site. Although, the 4-lithiated intermediate would result in 
the formation of 4,5-indole aryne upon elimination, this aryne would not be a major product 
of this reaction.  
 
4.5 Indole Aryne Cycloadditions in N-Me-4,5,6- and 4,5,7-Tribromoindoles 
With the sites of metal-halogen exchange in N-Me-4,5,6- and N-Me- 4,5,7-
tribromoindoles established, we next attempted to generate arynes in these systems and 
subsequently trap them with a diene to provide evidence for the existence of these 
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intermediates. Thus, N-Me-4,5,6-tribromoindole was treated with a slight excess of n-BuLi at 
-78° C in PhMe to induce a selective and exclusive metal-halogen exchange at C-4. Upon 
warming up the reaction mixture to -40 to -35° C, the 4-lithiated intermediate underwent an 
elimination of LiBr to generate the 6-bromo-4,5-indole aryne which was subsequently 
trapped with cyclopentadiene in a [4 + 2] Diels-Alder cycloaddition reaction to yield the 
corresponding 6-bromo-4,5-benzannulated product in 65% yield (Scheme 4.10). 
Scheme 4.10. Indole aryne generation and trapping in N-Me-4,5,6-tribromoindole. 
 Surprising results were obtained when N-Me-4,5,7-tribromoindole was subjected to 
metal-halogen exchange and elimination protocol. The metal-halogen exchange studies for 
this scaffold had suggested the 7-lithiated species to be the major product of this reaction. 
Thus, the result of this reaction would have been the formation of N-Me-4,5-dibromoindole 
as the predominant product whereas, the 4,5-indole aryne cycloaddition product to be the 
minor one. However, when N-Me-4,5,7-tribromoindole was subjected to metal-halogen 
exchange and elimination protocol, the 4,5-indole aryne cycloaddition product 4.46 was 
formed as the sole product, none of the N-Me-4,5-dibromoindole 4.41 was observed (Scheme 
4.11).  
 
Scheme 4.11. Indole aryne generation and trapping in N-Me-4,5,7-tribromoindole. 
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 This intriguing observation could be rationalized on the basis of a hypothesis that the 
initial metal-halogen exchange occurs at C-7 as demonstrated however, this 7-lithiated 
species 4.39 itself acts as a lithiating reagent and performs a subsequent metal-halogen 
exchange at the C-4 site of an unreacted N-Me-4,5,7-tribromoindole to give exclusively 4.40. 
This intermediate upon elimination forms exclusively the 6-bromo-4,5-indole aryne 4.45 
which undergoes cycloaddition with cyclopentadiene (Scheme 4.12). 
Scheme 4.12. Plausible mechanism for C-4 lithiation in N-Me-4,5,7-tribromoindole . 
 
4.6 Regioselectivity in 4,5-Indole Aryne Cycloadditions in N-Me-4,5,6- and 4,5,7-
Tribromoindoles 
 
Subsequently, we investigated the regioselectivity in the 4,5-indole aryne 
cycloadditions in these scaffolds with 2-substituted furans. Thus, when the 4,5-indole aryne 
generated in N-Me-4,5,6-tribromoindole was trapped with 2-tert-butylfuran, virtually no 
regioselectivity was observed (1.3:1) with the two regioisomers formed in almost equal 
proportions (Scheme 4.13).  
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Scheme 4.13. Regioselective cycloadditions of 6-bromo-4,5-indole aryne with 2-tert-
butylfuran . 
 
This observation is consistent with the regiochemical outcome in the N-Me-5,6,7-
tribromoindole case where the regioselectivity ratio was comparable (1.4:1). Apparently, the 
presence of a bromine adjacent to the site of aryne formation is not very beneficial for the 
regioselectivity of these cycloaddition reactions.  
On the other hand, when 7-bromo-4,5-indole aryne was trapped with 2-tert-
butylfuran, the regiochemical distribution was slightly enhanced with the two regioisomers 
formed in a 2:1 ratio (Scheme 4.13). Again, this observation is consistent with the 
regiochemical outcome in the N-Me-4,6,7-tribromoindole case where the regioselectivity 
ratio was comparable (3:1). It appears that in both these systems, as the bromine moves one 
carbon atom away from the site of aryne formation, there is a slight improvement in the 
regioselectivity of these cycloaddition reactions. 
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Scheme 4.14. Regioselective cycloadditions of 7-bromo-4,5-indole aryne with 2-tert-
butylfuran . 
 
4.7 N-Me-4,5,6- and 4,5,7-Tribromoindoles as Templates for Library Construction 
 
The Buszek laboratory has a long-standing interest in the development of new 
chemotypes (new chemical entities) based on heteroaromatic systems, especially indoles. The 
compelling biological results obtained from our previously synthesized 4-substituted-6,7-
benzannulated indoles have already validated the significance of annulated indoles in library 
development. In connection to these previous efforts, we were prompted to exploit the newly 
synthesized N-Me-4,5,6- and N-Me-4,5,7-tribromoindole scaffolds toward library 
construction. We envisioned that the 4,5-region of these scaffolds would serve as the aryne 
cycloaddition region whereas, the remaining unreacted 6- and 7-bromo positions could be 
subjected to Pd(0)-catalyzed cross-coupling chemistry to install various adornments at these 
sites. However, the important question was whether or not the bromine substituents in these 
scaffolds would serve as good partners in cross-coupling reactions. 
To demonstrate the proof-of-concept, the remaining unreacted 6-bromo position in 
4.44 was subjected to Pd(0)-catalyzed Negishi cross-coupling reaction with dimethylzinc. 
Gratifyingly, the C-6 bromo position readily underwent the cross-coupling protocol to install 
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a methyl substituent at this site in 72% yield (Scheme 4.14). Likewise, under identical 
Negishi conditions, an ethyl group was successfully incorporated at the C-6 site to yield 4.54 
in 75% yield thus, providing the first ever examples of 6-substituted-4,5-benzannulated 
indoles. 
 
Scheme 4.15. Negishi cross-coupling reactions in 6-bromo-4,5-benzannulated indoles. 
 
In a similar manner, the remaining unreacted 7-bromo position in 4.46 was subjected 
to Pd(0)-catalyzed Negishi cross-coupling reactions with dimethylzinc and diethylzinc to 
install substitution patterns at these sites in excellent yield thus, providing the first ever 
examples of 7-substituted-4,5-benzannulated indoles (Schemes 4.15). 
 
Scheme 4.16. Negishi cross-coupling reactions in 7-bromo-4,5-benzannulated indoles. 
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4.8 Future Directions 
 
With the proof-of-concept already established, the future efforts will be directed 
towards subjecting the keys scaffolds 4.44 and 4.46 to a series of Pd(0)-catalyzed cross-
coupling reactions involving Buchwald-Hartwig, Suzuki-Miyaura, Negishi, Sonogashira, 
Stille and Heck to construct a collection of structurally diverse 6- and 7-substituted-4,5-
benzannulated indole library members (Schemes 4.16 and 4.17).  
 
Scheme 4.17. Various cross-coupling reactions in 6-bromo-4,5-benzannulated indoles. 
 
These newly synthesized library members will be screened in various cell-based 
assays to ascertain their biological activities.  
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Scheme 4.18. Various cross-coupling reactions in 7-bromo-4,5-benzannulated indoles. 
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CHAPTER 6 
EXPERIMENTAL SECTION 
6.1 General Details 
1H-NMR (400 MHz) and 13C-NMR (100 MHz) were performed in CDCl3 unless 
otherwise noted with reference to residual solvent at  7.26 ppm and 77.0 ppm respectively.  
Melting points reported are uncorrected.  Unless otherwise noted, all commercially obtained 
starting materials were used as received.  n-Butyllithium was titrated against 2-butanol in 
anhydrous THF with 1,10-phenanthroline as an indicator prior to use.  Tetrahydrofuran and 
diethyl ether were distilled from sodium and benzophenone under nitrogen prior to use.  
Toluene was distilled from calcium hydride under nitrogen prior to use.  Temperatures of -78 
C were obtained through use of a dry-ice acetone cold bath. Microwave reactions were 
carried out using a Biotage Initiator microwave reactor at the times and temperatures 
indicated. 
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6.2. Experimental procedures 
 
 
1,2,3-Tribromobenzene (2.17): In a 500-mL round-bottom flask was dissolved 5.78 g (25.9 
mmol) of CuBr2 in 200 mL of dry CH3CN and the mixture heated to 60 °C. To this warm 
solution was added 3.80 mL (31.9 mmol) tert-butyl nitrite, followed by a solution of 5.01 g 
(19.9 mmol) of commercially available 2,6-dibromoaniline 2.18 in 50 mL CH3CN. The 
mixture was stirred at 60 °C for 1 h, then cooled to room temperature and poured into 200 
mL 20% aqueous ammonia. The mixture was extracted with hexane (2 x 200 mL) and the 
combined organic phase was washed sequentially with 20% aqueous ammonia (100 mL), 
water (100 mL), brine (50 mL), and then dried over anhydrous magnesium sulfate. The 
contents were filtered and concentrated under reduced pressure. The resulting crude material 
was recrystallized from ethanol to give 5.12 g (80%) of 1,2,3-tribromobenzene 2.17 as an 
off-white solid, mp =  88-90 °C. 1H NMR (CDCl3): d, J = 8.0 Hz, 2 H), 7.03 (t, J = 
8.0 Hz, 1 H); 13C NMR (CDCl3):  132.6, 129.2, 127.7, 126.2.  
 
 
1,2,3-Tribromo-4-nitrobenzene (2.16): In a 250-mL round-bottom flask was dissolved 5.00 
g (15.9 mmol) of 2.17 in 100 mL of 1,2-dichloroethane and the mixture cooled to 0 °C. To 
the vigorously stirred solution at 0 °C was added 7.00 mL (159 mmol) of fuming HNO3 
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dropwise over 15 minutes. The mixture was stirred at 0 °C for 1 h and then poured over 500 
mL of ice. After 30 minutes, 100 mL of CH2Cl2 was added and the organic layers extracted 
with water (3 x 100 mL), saturated NaHCO3 (3 x 100 mL), brine (100 mL), and then dried 
over anhydrous magnesium sulfate. The contents were filtered and concentrated under 
reduced pressure. The crude material was recrystallized from hexanes to give 4.74 g (82%) of 
2,3,4-tribromonitrobenzene 2.16 as an off-white solid: mp = 82-84 °C. 1H NMR (CDCl3): 
d, J = 8.6 Hz, 1 H), 7.51 (d, J = 8.6 Hz, 1 H); 13C NMR (CDCl3):  132.6, 132.5, 
131.1, 130.1, 123.7, 118.7; HRMS (EI) m/e calcd for C6H2Br3NO2 356.7635, found 
356.7633.  
 
 
5,6,7-Tribromoindole (2.25) via Bartoli route: In 250-mL round-bottom flask was 
dissolved 2.01 g (5.55 mmol) of 2.16 in 20 mL of dry THF and cooled to -40 °C.  To the 
vigorously stirred solution was added 16.7 mL (16.7 mmol) of 1 M vinyl magnesium 
bromide via syringe at once. The mixture was stirred for 1 h. The mixture was quenched with 
100 mL saturated NH4Cl and then extracted with diethyl ether (2 x 100 mL) and the 
combined organic phase was washed sequentially with water (100 mL), brine (50 mL), and 
dried over anhydrous magnesium sulfate. The material was filtered and concentrated under 
reduced pressure. The crude material was then purified via flash column chromatography on 
silica gel using 10% EtOAc (ethyl acetate) in hexanes as the eluent to give 0.628 g (32%) of 
2.25 as a white solid, mp = 132-134 °C. 1H-NMR (CDCl3):  (bs, 1 H, NH); 7.89 (s, 1 
H);  7.27 (dd, J = 3.3, 3.3 Hz, 1 H); 6.57 (dd, J = 3.3, 3.3 Hz, 1 H). 13C-NMR (CDCl3):  
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134.8, 128.2, 126.4, 124.0, 119.2, 115.5, 107.9, 103.5; HRMS (EI) m/e calcd for C8H4Br3N 
350.7893, found 350.7891.  
 
 
2,6-Dibromo-4-methylaniline (2.27): In 500-mL round-bottom flask was dissolved 10.7 g 
(100 mmol) 2.26 in 300 mL of dry methanol. To the vigorously stirred solution was carefully 
added 50.6 mL (300 mmol) concentrated aqueous HBr (47% wt/wt) followed by 22.7 mL 
(200 mmol) 30% aqueous H2O2 dropwise over 15 minutes. The mixture was stirred 
overnight. The mixture was poured into 1.0 L of 1 M NaOH and the resulting suspension was 
filtered and washed with water until neutral. Dried under vacuum at 50 °C gave 26.2 g (99%) 
of 2.27 as a purple amorphous solid (mp = 74-76 °C) whose physical properties were 
identical to that of the commercially available compound. 
 
 
3,4,5-Tribromotoluene (2.28): In a 1-L round-bottom flask was dissolved 11.6 g (52.0 
mmol) CuBr2 in 300 mL of dry CH3CN and heated to 60 °C. To the warm solution was added 
7.6 mL (64 mmol) tert-butyl nitrite followed by a solution of 10.6 g (40.0 mmol) of 2.27 in 
100 mL of CH3CN. The mixture was stirred at 60 °C for 1 h. The solution was cooled to 
room temperature and poured into 400 mL of 20% aqueous ammonia. The mixture was 
extracted with hexane (2 x 400 mL) and the combined organic layers were washed 
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sequentially with 20% aqueous ammonia (200 mL), water (200 mL), brine (100 mL), and 
then dried over anhydrous magnesium sulfate. The solution was filtered and concentrated 
under reduced pressure. The crude material was recrystallized from ethanol to give 11.3 g 
(80%) of 2.28 as off-white needles, mp = 92-94 °C. 1H-NMR (CDCl3):  7.38 (s, 2 H), 2.24 
(s, 3 H); 13C-NMR (CDCl3):  139.4, 133.0, 125.4, 123.8, 20.4.  
 
 
1,2,3-Tribromo-5-methyl-4-nitrobenzene (2.29): In a 250-mL round-bottom flask was 
dissolved 10.0 g (30.9 mmol) of 2.28 in 100 mL of 1,2-dichloroethane and cooled to 0 °C. To 
the vigorously stirred solution at 0 °C was added 13.5 mL (309 mmol) of fuming HNO3 
dropwise over 15 minutes. The mixture was stirred at 0 °C for 1 h and then poured into 500 
mL of ice. After 30 minutes 100 mL of CH2Cl2 was added and extracted.  The organic layer 
was washed sequentially with water (3 x 200 mL), saturated NaHCO3 (3 x 100 mL), brine 
(100 mL), dried over anhydrous magnesium sulfate. The solution was filtered and 
concentrated under reduced pressure. The crude material was recrystallized from hexanes to 
give 9.46 g (82%) of 2.29 as off-white solid, mp = 106-108 °C. 1H NMR (CDCl3): 7.58 (s, 
1 H), 2.26 (s, 3 H); 13C NMR (CDCl3):  151.6, 134.4, 130.8, 127.3, 126.7, 117.0, 17.1; 
HRMS (EI) m/e calcd for C7H4Br3NO2 370.7791, found 370.7790.  
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5,6,7-Tribromoindole (2.25) via Leimgruber-Batcho route: In a 50-mL round-bottom 
flask a mixture of 6.52 g (17.4 mmol) 2.29 and 6.92 g (26.1 mmol) TPM was heated to 105 
°C under water-aspirator vacuum with vigorous stirring. After 3 h an aliquot of the mixture 
showed complete reaction by TLC (20% dichloromethane in hexane). Cooled to room 
temperature and passed through a plug of silica gel eluting with 50% tert-butyl methyl ether 
in hexanes and concentrated under reduced pressure to give 8.15 g of crude intermediate 
which was then suspended in 150 mL methanol in a 250 mL round-bottom flask and heated 
to reflux. To the red solution was added 0.305 g (1.13 mmol) FeCl3•6H2O and 0.689 g (57.4 
mmol) activated carbon. The mixture was refluxed for 5 minutes, and then 3.35 mL (68.7 
mmol) NH2NH2•H2O was added via a syringe over 10 minutes and refluxed for 1 h. The 
mixture was cooled to room temperature and filtered through a 1-cm pad of Celite, washing 
with methanol. The filtrate was concentrated under reduced pressure to about 5 mL, then 
diluted with 1M HCl (250 mL), extracted with CH2Cl2 (3 x 75 mL). The combined organic 
phases were washed with water (2 x 100 mL), brine (50 mL), and dried over anhydrous 
magnesium sulfate. The solution was filtered and concentrated under reduced pressure. The 
crude material was then purified via column chromatography on silica gel using 10% CH2Cl2 
in hexanes as eluent to give 3.68 g (61%) of 2.25 as a white solid, mp = 132-134 °C. 1H-
NMR (CDCl3): 8.36 (bs, 1 H, NH); 7.89 (s, 1 H); 7.27 (dd, J = 3.3, 3.3 Hz, 1 H); 6.57 (dd, 
J = 3.3, 3.3 Hz, 1 H). 13C-NMR (CDCl3):  134.8, 128.2, 126.4, 124.0, 119.2, 115.5, 107.9, 
103.5. HRMS (EI) m/e calcd for C8H4Br3N 350.7893, found 350.7891.  
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5,6,7-tribromo-1-methyl-1H-indole (2.31): In a 100 mL flame dried round bottom flask 
under argon was added 35 mg (0.10 mmol) of 5,6,7-tribromoindole 2.25. This was dissolved 
in 10 mL of dry THF and to this solution was added 5 mg (0.20 mmol) of dry sodium 
hydride. The solution was stirred at room temperature for 30 min, and then 13 µL (0.20 
mmol) of iodomethane was added via syringe. The resulting solution was stirred for 1 h, and 
then quenched by dropwise addition of aq. NH4Cl (20 mL). The aqueous mixture was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue 
was purified via flash column chromatography on silica gel using 1% TBME (tert-butyl 
methyl ether) in hexanes as eluent to give 32 mg (86%) of 5,6,7-tribromo-1-methyl-1H-
indole 2.31 as a white solid, mp = 147-149°C. 1H-NMR: 
sdJHzdJHzs 13C-NMR:  
136.21, 131.70, 126.61, 123.98, 120.85, 120.63, 109.77, 99.13, 35.70.
 
 
5,6-dibromo-1-methyl-1H-indole (2.33): In a flame-dried 50 mL round-bottom flask under 
argon was added a solution of 30 mg (0.08 mmol) 2.31 in 10 mL dry toluene and cooled to -
78 °C, then 64 µL (0.16 mmol) of a 2.5 M solution of n-butyllithium in hexanes was added 
dropwise via syringe over 15 min. The solution was stirred at -78 °C for 30 min and 
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quenched with water (2 mL) then allowed to slowly warm to room temperature. The reaction 
the mixture was diluted with water (5 mL) and extracted with diethyl ether (3 x 10 mL). The 
combined organic phase was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 1% TBME in hexanes as eluent to give 13 mg of 2.33 as 
a yellow oil. 1H-NMR (CDCl3):  7.88 (s, 1 H); 7.61 (d, J = 1.0 Hz, 1 H); 7.04 (d, J = 3.1 Hz, 
1 H); 6.40 (dd, J = 1.0, 3.1 Hz, 1 H); 3.75 (s, 3 H). 
 
 
5-bromo-1-methyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole (2.35): In a flame-dried 
25 mL round-bottom flask under argon was added a solution of 30 mg (0.08 mmol) 2.31 in 
10 mL dry toluene. To this was added 135 µL (1.6 mmol) of freshly cracked 
cyclopentadiene. The resulting solution was cooled to -78 °C, then 64 µL (0.16 mmol) of a 
2.5 M solution of n-butyllithium in hexanes was added dropwise via syringe over 15 min. 
The solution was stirred at -78 °C for 30 min then allowed to slowly warm to room 
temperature. The reaction was then quenched by addition of saturated NH4Cl (10 mL). After 
stirring for 5 minutes, the mixture was diluted with water (10 mL) and extracted with diethyl 
ether (3 x 20 mL). The combined organic phase was dried over anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure. The crude material was then 
purified via column chromatography on silica gel using 1% TBME in hexanes as eluent to 
give 16 mg (72%) of 2.35 as a yellow oil. 1H-NMR (CDCl3):  7.34 (d, J = 0.6 Hz, 1 H); 6.98 
(dd, J = 3.1, 5.3 Hz, 1 H); 6.90 (d, J = 3.1 Hz, 1 H); 6.88 (dd, J = 3.1, 5.3 Hz, 1 H); 6.33 (dd, 
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J = 0.6, 3.1 Hz); 4.60 (m, 1 H); 4.26 (m, 1 H); 2.39 (m, 2 H).   13C-NMR (CDCl3):  145.69, 
144.30, 143.06, 135.35, 131.95, 130.70, 129.87, 118.52, 108.81, 100.45, 71.01, 51.21, 49.39, 
35.17. 
 
 
5,6,7-Tribromo-1-(tert-butyldimethylsilyl)-1H-indole (2.15): In a flame-dried 250-mL 
three-neck round bottom flask under argon was added a solution of 1.00 g (2.82 mmol) 2.25 
in 50 mL dry THF. To this was added 0.271 g (11.3 mmol) of NaH followed by 0.80 mL (5.6 
mmol) Et3N. The resulting suspension was cooled to 0 °C for 15 min then 0.92 mL (5.6 
mmol) of tert-butyldimethylsilyl trifluoromethanesulfonate diluted in 5 mL pentane was 
added dropwise via syringe over 5 min. The solution was stirred at 0 °C for an additional 20 
minutes. The reaction was then diluted with diethyl ether (50 mL) and quenched by addition 
of saturated NH4Cl (100 mL). Then the mixture was extracted with diethyl ether (3 x 100 
mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered 
and concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 1% TBME in hexanes as the eluent to give 1.03 g (78%) 
of 2.15 as a colorless oil which solidified to a glass at room temperature. 1H-NMR (CDCl3): 
 (s, 1 H), 7.41 (d, J = 3.3 Hz, 1 H), 6.57 (d, J = 3.3 Hz, 1 H), 0.97 (s, 9 H), 0.72 (s, 6 
H); 13C-NMR (CDCl3):  140.5, 136.2, 133.8, 123.7, 121.3, 116.3, 109.7, 105.0, 27.4, 19.9, 
2.2; HRMS (EI) m/e calcd for C14H18Br3NSi 464.8758, found 464.8755. 
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5-Bromo-1-(tert-butyldimethylsilyl)-6,9-dihydro-1H-6,9-methanobenzo[g]indole (2.12): 
In a flame-dried 250 mL three- necked round-bottom flask under argon was added a solution 
of 0.610 g (1.30 mmol) 2.15 in 60 mL dry toluene. To this was added 1.72 g (26.0 mmol) of 
freshly cracked cyclopentadiene. The resulting solution was cooled to -78 °C, then 1.04 mL 
(2.60 mmol) of a 2.5 M solution of n-butyllithium in hexanes was added dropwise via 
syringe over 15 min. The solution was stirred at -78 °C for 30 min then allowed to slowly 
warm to room temperature. The reaction was then quenched by addition of saturated NH4Cl 
(50 mL). After stirring for 5 minutes, the mixture was diluted with water (100 mL) and 
extracted with diethyl ether (3 x 100 mL). The combined organic phase was dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The crude 
material was then purified via column chromatography on silica gel using 1% methyl tert-
butyl ether in hexanes as eluent to give 0.35 g (72%) of 2.12 as a colorless liquid which 
solidifies to a glass below room temperature. 1H NMR (CDCl3):  (s, 1 H); 7.16 (d, J = 
3.5 Hz, 1 H); 6.98 (dd, J = 5.3, 5.3 Hz, 1 H); 6.85 (dd, J = 5.3, 5.3 Hz, 1 H); 6.48 (d, J = 3.3 
Hz, 1 H);  4.58 (bs, 1 H); 4.26 (bs, 1 H); 2.30 (m, 2 H); 1.20 (s, 9 H); 0.67 (s, 3 H);  0.59 (s, 3 
H). 13C NMR (CDCl3):  145.9, 144.8, 142.4, 136.9, 136.0, 133.2, 133.1, 118.6, 109.6, 
104.5, 69.8, 52.0, 51.8, 26.6, 19.4, -1.4, -1.8. HRMS (EI) m/e calcd for C19H24BrNSi 
373.0862, found 373.0864.  
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5-bromo-1-(tert-butyldimethylsilyl)-6,7,8,9-tetrahydro-1H-6,9-methanobenzo[g]indole-
7,8-diol (2.36): In a 250 mL round-bottom flask was added 0.310 g (0.830 mmol) 2.12 and 
this was dissolved in 62.5 mL THF/water (1.5:1). To the solution was added 117 mg (0.863 
mmol) NMO hydrate. The mixture was stirred at room temperature, and one small crystal of 
OsO4 was added and the reaction was followed by TLC. After 6 h the TLC showed complete 
reaction. The reaction mixture was quenched by addition of saturated aq. NaHSO3 (10 mL), 
and the subsequent mixture was stirred rapidly for 30 min. The mixture was then extracted 
with ethyl acetate (3 x 75 mL), the combined organic phase was dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure. The crude material was 
purified via column chromatography on silica gel using 25% ethyl acetate in hexanes as 
eluent to give 0.26 g (75%) of 2.36 as colorless oil which solidified at room temperature. 1H-
NMR (CDCl3):  (d, J = 1.4 Hz, 1 H); 7.23 (dd, J = 3.3, 3.3 Hz, 1 H); 6.51 (dd, J = 3.3, 
3.3 Hz, 1 H); 3.90 (m, 1 H); 3.85-3.79 (m, 2 H); 3.56 (s, 1 H);  2.25 (d, J = 9.8 Hz, 1 H); 1.96 
(d, J = 9.8 Hz, 1 H); 0.98 (s, 9 H); 0.71 (s, 3 H);  0.59 (s, 3 H). 13C-NMR (CDCl3):  138.3, 
135.1, 133.9, 133.2, 129.8, 121.0, 109.5, 104.6, 70.9, 70.0, 51.6, 51.1, 41.9, 26.5, 19.4, -1.6, -
1.9. HRMS (EI) m/e calcd for C19H26BrNO2Si 407.0916, found 407.0918.  
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 (6R,8S)-5-bromo-1-(tert-butyldimethylsilyl)-1,6,7,8-tetrahydrocyclopenta[g]indole-6,8-
dicarbaldehyde (2.37): In a 250 mL round-bottom flask was added a solution of 0.200 g 
(0.490 mmol) 2.36 in 40 mL THF. To the stirred solution was added water (12 mL) followed 
by 1.57 g (7.35 mmol) NaIO4. The mixture was stirred at room temperature until TLC 
analysis indicated complete reaction, about 2 h. The mixture was diluted with ethyl acetate 
(150 mL) and water (150 mL). The phases were separated and the organic layer was washed 
with brine (25 mL) and dried over anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure. The crude material was passed through a plug of silica gel, eluting 
with 40% ethyl acetate in hexanes to give 0.198 g (99%) of 2.37 as pale yellow solid, mp = 
101-103 °C. 1H-NMR (CDCl3): ss (s, 1 H); 7.32 (d, J = 3.5 
Hz, 1 H); 6.62 (d, J = 3.3 Hz, 1 H); 4.56 (d, J = 9.2 Hz, 1 H); 4.20 (d, J = 9.2 Hz, 1 H); 2.96 
(d, J = 13.3 Hz, 1 H); 2.56 (m, 1 H); 0.76 (s, 9 H); 0.61 (s, 3 H);  0.59 (s, 3 H). 13C-NMR 
(CDCl3):  199.7, 199.0, 138.14, 135.6, 134.8, 133.3, 125.3, 123.9, 111.8, 105.2, 57.5, 56.9, 
27.9, 26.1, 20.0, -1.7, -1.6. HRMS (EI) m/e calcd for C19H24BrNO2Si 405.0760, found 
405.0766. 
 
(6R,8S)-6,8-bis(bis(ethylthio)methyl)-5-bromo-1,6,7,8-tetrahydrocyclopenta[g]indole 
(2.38): In a flame-dried 100 mL round-bottom flask under argon was added a solution of 
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0.180 g (0.443 mmol) 2.37 in 5 mL ethanethiol. This stirring solution was cooled to -78 oC 
and added 4 drops of BF3•OEt2 and the mixture was stirred at -78 °C for 15 min. The solution 
was then warmed to room temperature and followed by TLC. After a further 45 min, 
saturated sodium bicarbonate (20 mL) was added, and the mixture was extracted with 
dichloromethane (3 x 50 mL). The combined organic layer was dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure. The crude material was purified via 
column chromatography on silica gel using 5% methyl tert-butyl ether in hexanes as eluent to 
give 0.16g (74%) of 2.38 as pale yellow solid, mp = 73-75 °C. 1H-NMR (CDCl3): 
bss (t, J = 2.7 Hz, 1 H); 6.46 (dd, J = 2.9, 2.7 Hz, 1 H); 5.20 
(d, J = 3.3 Hz, 1 H); 4.64 (d, J = 8.4 Hz, 1 H); 3.98 (m, 1 H); 3.73 (m, 1 H); 2.96-2.22 (series 
of m, 8 H); 1.42-1.34 (m, 6 H); 1.14-1.08 (m, 6 H). 13C-NMR (CDCl3):   136.7, 133.0, 
129.8, 128.7, 125.0, 123.5, 110.9, 102.0, 55.8, 52.9, 51.24, 50.6, 34.0, 27.4, 26.8, 26.2, 25.6, 
15.1, 14.8, 14.7, 14.6. HRMS (EI) m/e calcd for C21H30BrNS4 503.0447, found 442.0333 (M 
– C2H5S).  
 
 
(6R,8S)-5-bromo-6,8-dimethyl-1,6,7,8-tetrahydrocyclopenta[g]indole (3.1) and (6R,8S)-
6,8-dimethyl-1,6,7,8-tetrahydrocyclopenta[g]indole (2.39): In a 100 mL round-bottom 
flask was added a solution of 44 mg (0.087 mmol) of  2.38 in 10 mL acetone.  To the stirring 
solution was added 2.0 g of Raney-Nickel (2800, Aldrich).  The resulting suspension was 
heated to reflux and monitored by TLC.  After 1 h, TLC analysis showed no starting material 
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and the mixture was cooled to room temperature and filtered through a pad of celite.  The 
residue was washed with acetone (3 x 10 mL) and diethyl ether (1 x 50 mL).  The combined 
filtrate was concentrated under reduced pressure. The crude material was purified via column 
chromatography on silica gel using 5% methyl tert-butyl ether in hexanes as eluent to give 
7.1 mg (31%) of 2.39 as colorless oil and 5.8 mg (36%) of 2.40 as colorless oil.  
1H-NMR (CDCl3):(2.39sdJHzdJHz
mmmdJHz
dJHzdJHzsss 
13C-NMR (CDCl3):   140.8, 131.7, 131.0, 129.0, 124.5, 122.2, 111.4, 102.5, 41.1, 41.0, 
37.9, 23.0, 22.5. HRMS (EI) m/e calcd for C13H14BrN 263.0310, found 263.0310.
1H-NMR (CDCl3): (2.40). 8.08 bsdJHz
ddJHz,dJHzmm
mdtJHzdJHz
dJHzm 13C-NMR (CDCl3):   132.6, 129.2, 127.2, 123.3, 
119.0, 115.6, 102.9, 44.5, 38.8, 37.3, 21.0, 20.7. HRMS (EI) m/e calcd for C13H15N 
185.1205, found 185.1204. 
 
 
((6R,8S)-5-bromo-1-(tert-butyldimethylsilyl)-1,6,7,8-tetrahydrocyclopenta[g]indole-6,8-
diyl)dimethanol (2.11): In a 100 mL round-bottom flask was added a solution of 0.130 g 
(0.319 mmol) 2.37 in 30 mL THF. To the stirred solution was added 0.123 g (3.19 mmol) 
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NaBH4 in small portions at 0 °C. The mixture was stirred at 0 °C for 15 minutes. Water (50 
mL) was added to the mixture and extracted with ethyl acetate (3 x 50 mL). The combined 
organic phase was washed with brine (25 mL) and dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. The crude material was recrystallized from 
hexanes (2 times) to give 0.112 g (86%) of 2.11 as white solid, mp = 168-170 °C. 
RDMSO-d6dJHzsdJHz
tJHztJHztJHzm
mmdtJHz
mtJHzsss13C-
NMR (DMSO-d6):   137.9, 136.2, 135.1, 134.5, 131.0, 122.4, 111.9, 105.1, 64.6, 64.1, 48.7, 
48.0, 28.8, 26.3, 20.4, -1.6, -2.8. HRMS (EI) m/e calcd for C19H28BrNO2Si 409.1073, found 
409.1074.
 
 
 ((6R,8S)-5-bromo-1-(tert-butyldimethylsilyl)-1,6,7,8-tetrahydrocyclopenta[g]indole-6,8-
diyl)bis(methylene) dimethanesulfonate (2.41): In a flame-dried 100 mL round-bottom 
flask under argon was added a solution of 0.112 g (0.273 mmol) 2.11 in 30 mL dry CH2Cl2. 
To this stirring solution was added 0.17 mL (1.091 mmol) Et3N followed by 0.05 mL (0.600 
mmol) methanesulfonyl chloride at 0 °C. The reaction mixture was stirred overnight (12 h). 
Water was added and extracted with CH2Cl2 (3 x 25 mL). The combined organic phase was 
washed with brine (25 mL) and dried over anhydrous magnesium sulfate, filtered and 
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concentrated under reduced pressure. The crude material was purified via column 
chromatography on silica gel using 25% EtOAc in hexanes as eluent to give 0.126 g (82%) 
of 2.41 as colorless oil. 1H-NMR (CDCl3): 
sdJHzdJHzddJHz
ddJHzm m 4.00 (t, J = 
9.6, 1 H); 3.82-3.76 (m, 1 H); 2.98 (s, 3 H); 2.96 (s, 3 H); 2.61-2.50 (m, 1 H); 2.36 (d, J = 
14.5 Hz, 1 H); 0.79 (s, 3 H); 0.65 (s, 9 H); 0.63 (s, 3 H). 13C-NMR (CDCl3):   138.0, 135.7, 
135.4, 133.6, 127.8, 124.5, 111.8, 105.6, 71.4, 71.3, 60.3, 45.1, 44.5, 36.9, 29.6, 26.2, 20.7, -
1.5, -2.6. HRMS (EI) m/e calcd for C21H32BrNO6S2Si 565.0624, found 470.0825 (M – 
CH3SO3). 
 
 
 (6R,8S)-5-bromo-1-(tert-butyldimethylsilyl)-6,8-dimethyl-1,6,7,8-
tetrahydrocyclopenta[g]indole (2.10): In a 15 mL sealed tube was added a solution of 
0.120 g (0.211 mmol) 2.41 in dry glyme. To this was added 0.514 g (3.40 mmol) NaI 
followed by 0.891 g (13.625 mmol) Zn powder. The mixture was heated to 90 °C for 6 h. 
The mixture was cooled to room temperature, diluted with ethyl acetate (150 mL) and 
washed with water (5 x 50 mL), brine (25 mL), dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. The crude material was purified via column 
chromatography on silica gel using 1% TBME in hexanes as eluent to give 0.046 g (58%) of 
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2.10 as colorless oil. 1H-NMR 
(CDCl3)sdJHzdJHz 
mmmdJHz
dJHzdJHzsss 
13C-NMR (CDCl3):   140.8, 137.5, 134.9, 134.4, 133.9, 122.5, 112.5, 105.2, 40.4, 40.0, 
39.9, 30.9, 26.4, 24.2, 22.2, 20.8, -1.3, -2.5.  
HRMS (EI) m/e calcd for C19H28BrNSi 377.1175, found 377.1174. 
 
 
 (6R,8S)-5-bromo-6,8-dimethyl-1,6,7,8-tetrahydrocyclopenta[g]indole (2.39): In a 50 mL 
round-bottom flask was added a solution of 0.040 g (0.105 mmol) 2.10 in dry THF. To the 
stirred solution at 0 °C was added 0.21 mL (0.210 mmol) of 1.0 M TBAF in THF dropwise. 
The mixture was stirred at room temperature until TLC analysis indicated complete reaction, 
about 1 h. Water was added (25 mL) and extracted with ether (3 x 25 mL). The combined 
organic phase was washed with brine (15 mL) and dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. The crude material was purified via column 
chromatography on silica gel using 5% TBME in hexanes as eluent to give 0.023 g (82%) of 
2.39 as colorless oil. 1H-NMR: bssdJHz 
dJHzmmm
dJHzdJHz13C-NMR:   140.8, 131.7, 131.0, 129.0, 
124.5, 122.2, 111.4, 102.5, 41.1, 41.0, 37.9, 23.0, 22.5. 
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HRMS (EI) m/e calcd for C13H14BrN 263.0310, found 263.0311.
 
 
(±)-cis-Trikentrin B: To a 5-mL Biotage microwave vial was added 20 mg (0.076 mmol) of 
2.39,  39 mg (0.11 mmol) of the vinyl tin reagent 2.42, 1.7 mg (2.5 mol%) Pd2(dba)3 and 2.3 
mg (10 mol%) AsPh3 in dry tetrahydrofuran (4.0 mL). At this point the vial was sealed and 
placed in the microwave reactor. The contents of the vial were heated to 150 °C for a total 
time of 23 min (set time = 20 min; ramp and cool time = 3 min; power setting = high). After 
cooling, the vial was opened and the contents transferred to a 25-mL round-bottom flask, the 
vial rinsed with diethyl ether (10 mL), ethyl acetate (5 mL), and the combined organic 
solutions concentrated under reduced pressure. The residue was purified via flash 
chromatography using 10% EtOAc in hexanes to give 13 mg (73%) of (±)-cis-trikentrin B as 
a pale yellow oil. 1H-NMR (CDCl3):  (bs, 1 H, NH), 7.62 (s, 1 H), 7.15 (dd, J = 3.1, 2.2 
Hz, 1 H), 6.60 (d, J = 15.8 Hz, 1 H), 6.55 (dd, J = 3.1, 2.2 Hz, 1 H), 6.18 (dt, J = 15.8, 6.8 
Hz, 1 H), 3.55-3.40 (m, 2 H), 2.72 (ddd, J = 13.1, 9.0, 9.0 Hz, 1 H), 2.30-2.20 (m, 2 H), 1.56 
(m, 1 H), 1.45 (d, J = 7.0 Hz, 3 H), 1.35 (d, J = 6.8 Hz, 3 H), 1.12 (t, J = 7.2 Hz, 3 H). 13C-
NMR (CDCl3): , 131.9, 131.1, 129.1, 127.6, 127.4, 127.3, 123.7, 115.6, 103.0, 41.8, 
38.4, 37.1, 26.3, 24.2, 22.5, 14.0.  
HRMS (EI) m/e calcd for C17H21N 239.1675, found 239.1674. 
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Regioselective studies 
 
6,7-dibromo-3-(4-methoxyphenyl)-1H-indole (3.13.b): In a sealed tube was added 500 mg 
of (2,3-dibromophenyl)hydrazine hydrochloride 3.11 (1.65 mmol). This was dissolved in 20 
mL of ethanol. To this was added 0.20 mL (2.31 mmol, 1.4 eq) of 2-(4-methoxyphenyl) 
acetaldehyde. The mixture was heated to 100 oC for 2 h, then cooled to room temperature and 
concentrated under reduced pressure. The residue was diluted with TBME (50 mL) and the 
organic layer was washed with aq. NaHCO3 (20 mL), water (20 mL) and brine (10 mL). The 
organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under 
reduced pressure. The residue was purified via flash column chromatography on silica gel 
using 20% TBME in hexanes as eluent to give 6,7-dibromo-3-(4-methoxyphenyl)-1H-indole 
3.13.b in 62% as yellow oil. 1H-NMR: 8.08 bs, 1 H), s, 1 H), dd, J = 2.0, 6.8 
Hz, 2 H), 7.53 (dd, J = 2.5, 7.2 Hz, 1 H), m, 1 H), dd, J = 2.0, 6.8 Hz, 2 H), 3.84 
(s, 3 H). 13C NMR:  158.41, 136.34, 128.74, 128.62, 126.94, 124.78, 122.73, 122.04, 
119.88, 117.56, 114.32, 113.89, 55.34 
 
 
6,7-Dibromo-3-(4-fluorophenyl)-1H-indole (3.13.c): Obtained as above from the reaction 
between 2,3-dibromophenylhydrazine and 4-fluorophenylacetaldehyde as orange oil. Yield: 
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263 mg (38%); 1H-NMR:  8.46 (bs, 1 H), 7.65 (dd, J = 0.7, 8.4 Hz, 1 H), 7.55 (dd, J = 5.5, 
8.9 Hz, 2 H), 7.41 (d, J = 8.4 Hz, 1 H), 7.36 (d, J = 2.7 Hz, 1 H), 7.16 (apparent triplet, J = 
8.9 Hz, 2 H); 13C-NMR:  162.98, 160.53, 130.49 (d, J = 3.7 Hz), 129.07 (d, J = 8.1 Hz), 
125.41, 125.10, 122.43, 119.71, 119.01, 117.87, 115.91 (d, J = 22.1 Hz), 107.52; HRMS (EI) 
m/e calcd for C14H8FBr2N 366.9007, found 366.9000. 
 
 
 
3-Benzyl-6,7-dibromo-1H-indole (3.13.d): Obtained as above from the reaction between 
2,3-dibromophenylhydrazine and 2-phenylpropionaldehyde as brown oil. Yield:  281 mg 
(40%); 1H-NMR:  8.12 (bs, 1 H), 7.32-7.20 (m, 7 H), 6.94 (s, 1 H), 4.06 (s, 2 H); 13C-NMR: 
 140.37, 136.21, 128.48, 128.40, 127.06, 126.08, 124.13, 123.39, 119.34, 117.33, 117.23, 
107.07, 31.43; HRMS (EI) m/e calcd for C15H11Br2N 362.9258, found 362.9261. 
 
 
 
3-Benzyl-6,7-dibromo-1H-indole (3.13.e): Obtained as above from the reaction between 
2,3-dibromophenylhydrazine and butyraldehyde as yellow oil. Yield:  281 mg (48%); 1H-
NMR:  8.04 (bs, 1 H), 7.34 (d, J = 7.9 Hz, 1 H), 7.22 (d, J = 7.9 Hz, 1 H), 7.09 (s, 1 H), 2.68 
(q, J = 8.2 Hz, 2 H), 1.25 (t, J = 8.2 Hz, 3 H); 13C-NMR:  136.16, 126.92, 123.84, 121.57, 
120.36, 119.02, 117.15, 106.98, 18.36, 14.35; HRMS (EI) m/e calcd for C10H9Br2N 
300.9101, found 300.9111. 
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6,7-Dibromo-2-phenyl-1H-indole (3.13.f): In a 50 mL round bottom flask under argon was 
added 500 mg of 2,3-dibromophenylhydrazine (1.88 mmol). This was dissolved in 5 mL 
ethanol. To this were added 0.22 mL of acetophenone (1.88 mmol, 1.0 eq) and few drops of 
glacial acetic acid. The reaction mixture was heated to reflux for 2 h, then cooled to room 
temperature and concentrated under reduced pressure to get the hydrazone intermediate. The 
hydrazone was added to 5 g of polyphosphoric acid and heated to 120 oC for 2 h. The 
reaction mixture was then cooled to room temperature and poured over ice. The aqueous 
mixture was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were 
neutralized with 2M NaOH, washed with water (20 mL) and brine (20 mL). The organic 
layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography on silica gel using 20% 
TBME in hexanes as eluent to give 271 mg (41%) of 6,7-dibromo-2-phenyl-1H-indole as a 
yellow foam. 1H-NMR:   8.47 (bs, 1 H), 7.71 (d, J = 9.7 Hz, 1 H), 7.51-7.34 (m, 6 H), 6.87 
(s, 1 H); 13C-NMR:  139.13, 136.58, 131.33, 129.14, 128.72, 128.40, 125.33, 125.05, 
120.59, 117.29, 106.88, 101.03; HRMS (EI) m/e calcd for C14H9Br2N 348.9102, found 
348.9106. 
 
 
6,7-Dibromo-2,3-diphenyl-1H-indole (3.13.g): Obtained as above from the reaction of 2,3-
dibromophenylhydrazine and deoxybenzoin as light yellow foam. Yield: 312 mg (39%); 1H-
NMR:  8.46 (bs, 1 H), 7.45 (m, 4 H), 7.38-7.29 (m, 8 H); 13C-NMR:  137.88, 135.98, 
133.85, 132.86, 130.46, 129.34, 128.75, 128.58, 128.30, 127.23, 126.04, 125.29, 121.70, 
121.15, 116.52, 111.33; HRMS (EI) m/e calcd for C20H13Br2N 424.9415, found 424.9406. 
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6,7-Dibromo-3-(4-methoxyphenyl)-1-methyl-1H-indole (3.14.b): In a 50 mL flame dried 
round bottom flask under argon was added 300 mg (0.79 mmol) of 6,7-dibromo-3-(4-
methoxyphenyl)-1H-indole. This was dissolved in 20 mL of dry THF and to this solution was 
added 38 mg (1.56 mmol, 2.0 eq) of dry sodium hydride. The solution was stirred at room 
temperature for 30 min, and then 0.10 mL (1.56 mmol, 2.0 eq) of iodomethane was added via 
syringe. The resulting solution was stirred for 1 h, and then quenched by dropwise addition 
of aq. NH4Cl. The aqueous mixture was extracted with diethyl ether (3 x 25 mL). The 
combined organic layers were dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The residue was purified via flash column 
chromatography on silica gel using 20% TBME in hexanes as eluent to give 268 mg (86%) 
of 6,7-dibromo-3-(4-methoxyphenyl)-1-methyl-1H-indole as a yellow oil. 1H-NMR: 
d, J = 8.6 Hz, 1 H), d, J = 8.4 Hz, 2 H),d, J = 8.6 Hz, 1 H),s, 1 
H),d, J = 8.4 Hz, 2 H),s, 3 H),s, 3 H); 13C-NMR:  158.34, 130.05, 
129.68, 128.82, 128.09, 126.67, 124.81, 119.88, 119.82, 116.40, 114.28, 106.79, 55.32, 
37.77; HRMS (EI) m/e calcd for C16H13Br2NO 392.9364, found 392.9366. 
 
 
6,7-Dibromo-3-(4-fluorophenyl)-1-methyl-1H-indole, (3.14.c): Obtained as above from 
6,7-dibromo-3-(4-fluorophenyl)-1H-indole as orange oil. Yield: 336 mg (81%); 1H-NMR:   
7.58 (d, J = 8.4 Hz, 1 H), 7.48 (dd, J = 5.5, 8.9 Hz, 2 H), 7.38 (d, J = 8.4 Hz, 1 H), 7.14 
(apparent triplet, J = 8.9 Hz, 2 H), 7.09 (s, 1 H), 4.20 (s, 3 H); 13C-NMR:  162.55, 161.08, 
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157.52, 154.82, 133.76, 131.62, 129.96, 128.72, 126.38, 111.10, 108.22, 96.55, 30.91; 
HRMS (EI) m/e calcd for C15H10FBr2N 380.9164, found 380.9169. 
 
 
6,7-Dibromo-1-methyl-3-benzyl-1H-indole, (3.13.d): Obtained as above as an orange solid. 
Yield: 394 mg (98%); mp: 78-81 °C; 1H-NMR:   7.35-7.24 (m, 7 H), 6.67 (s, 1 H), 4.03 (s, 2 
H), 4.00 (s, 3 H); 13C-NMR:  140.37, 134.59, 130.77, 129.26, 128.40, 128.27, 125.95, 
123.87, 119.33, 119.14, 113.85, 106.38, 37.15, 30.94; HRMS (EI) m/e calcd for C16H13Br2N 
376.9415, found 376.9418. 
 
 
6,7-Dibromo-3-ethyl-1-methyl-1H-indole, (3.14.e): Obtained as above from 6,7-dibromo-
3-ethyl-1H-indole as yellow oil. Yield:  343 mg (82%); 1H-NMR:  7.35 (d, J = 8.2 Hz, 1 H), 
7.31 (d, J = 8.2 Hz, 1 H), 6.76 (s, 1 H), 4.09 (s, 3 H), 2.71 (q, J = 7.4 Hz, 2 H), 1.31 (t, J = 
7.4 Hz, 3 H); 13C-NMR:  134.63, 129.41, 129.19, 123.65, 119.24, 118.97, 116.98, 106.38, 
37.21, 17.77, 14.30; HRMS (EI) m/e calcd for C11H11Br2N 314.9258, found 314.9264. 
 
 
 
6,7-Dibromo-1-methyl-2-phenyl-1H-indole, (3.14.f): Obtained as above from 6,7-dibromo-
2-phenyl-1H-indole as yellow foam. Yield: 327 mg (79%); 1H-NMR:   7.41-7.20 (m, 7 H), 
6.42 (s, 1 H), 3.93 (s, 3 H); 13C-NMR:  144.69, 136.69, 132.05, 129.75, 129.59, 128.56, 
128.38, 125.20, 120.56, 119.65, 107.00, 102.62, 35.49; HRMS (EI) m/e calcd for C15H11Br2N 
362.9258, found 362.9266. 
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6,7-Dibromo-1-methyl-2,3-diphenyl-1H-indole, (3.14.g): Obtained as above from 6,7-
dibromo-2,3-diphenyl-1H-indole as light yellow foam. Yield: 323 mg (78%); 1H-NMR:   
7.52 (d, J = 8.6 Hz, 1 H), 7.49 (d, J = 8.6 Hz, 1 H), 7.37 (m, 4 H), 7.29-7.24 (m, 4 H), 7.19 
(m, 3 H), 4.01 (s, 3 H); 13C-NMR:  140.72, 135.78, 133.93, 131.19, 131.16, 129.91, 128.45, 
128.43, 128.41, 128.25, 126.09, 125.28, 120.15, 119.65, 115.82, 106.95, 35.24; HRMS (EI) 
m/e calcd for C21H15Br2N 438.9572, found 438.9568. 
 
 
4-fluoro-2-nitroaniline (3.16.a): In a 250 mL round-bottom flask was added 11.12 g (115 
mmol) acetic anhydride and 100 mL 1,2-dichloroethane. To this was added 11.1 g (100 
mmol) 4-fluoroaniline (3.15.a) and the solution was heated to 50 °C for 30 min. To the 
mixture, 10.1 mL (240 mmol) of fuming nitric acid was added dropwise over 45 min. The 
solution was then stirred at 50 °C for 3 h. The mixture was poured over ice. The mixture was 
diluted with CH2Cl2 (200 mL) and washed with 1M NaOH until neutral. The organic phase 
was washed with water (100 mL) and brine (50 mL). The organic layer was dried over 
anhydrous magnesium sulfate, filtered and concentrated.  In a 250 mL round-bottom flask the 
crude mixture was dissolved in 100 mL of glyme. To the stirring solution was added conc. 
HCl (25 mL) dropwise and the mixture was heated to reflux. After 2 h, TLC analysis showed 
complete hydrolysis of the intermediate amide and the mixture was cooled to room 
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temperature. The crude reaction mixture was extracted with ethyl acetate (3 x 100 mL), the 
organic layer was then washed with brine (50 mL), dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure to give 13.88 g (98%) of the title compound 
as an yellow crystalline solid, mp = 90-92 °C whose physical properties were identical to that 
of the commercially available compound. 
 
 
2-bromo-4-fluoro-6-nitroaniline (3.17.a): In 500-mL round-bottom flask was dissolved 7.8 
g (50 mmol) 3.16.a in 150 mL of methanol. To the vigorously stirred solution was carefully 
added 25.3 mL (150 mmol) concentrated aqueous HBr (47% wt/wt) followed by 11.4 mL 
(100 mmol) 30% aqueous H2O2 dropwise over 15 minutes. The mixture was stirred 
overnight. The mixture was poured into 1.0 L of 1 M NaOH and the resulting suspension was 
filtered and washed with water until neutral. Dried under vacuum at 50 °C gave 10.46 g 
(89%) of 3.17.a as a yellow solid, mp = 70-72 °C whose physical properties were identical to 
that of the commercially available compound. 
 
 
1,2-dibromo-5-fluoro-3-nitrobenzene (3.18.a): In a 1-L round-bottom flask was dissolved 
7.25 g (32.5 mmol) CuBr2 in 150 mL of dry CH3CN and heated to 60 °C. To the warm 
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solution was added 4.75 mL (40 mmol) tert-butyl nitrite followed by portion wise addition of 
5.9 g (25.0 mmol) of 3.17.a. The mixture was stirred at 60 °C for 1 h. The solution was 
cooled to room temperature and poured into 200 mL of 10% aqueous ammonia. The mixture 
was extracted with TBME (3 x 100 mL) and the combined organic layers were washed 
sequentially with 10% aqueous ammonia (100 mL), water (100 mL), brine (50 mL), and then 
dried over anhydrous magnesium sulfate. The solution was filtered and concentrated under 
reduced pressure. (75%) of 3.18.a as brown-white needles, mp = 66-68 °C. 1H-NMR 
(CDCl3): 7.64 (dd, J = 2.8, 7.2 Hz, 1 H); 7.44 (dd, J = 2.8, 7.2 Hz, 1 H).13C-NMR 
(CDCl3):  161.69, 159.14, 128.53 (d, J = 9.5 Hz), 124.20 (d, J = 24.2 Hz), 112.64 (d, J = 4.4 
Hz), 111.90 (d, J = 26.3 Hz). 
 
 
6,7-dibromo-4-fluoro-1H-indole (3.19.a): In a 250 mL flame-dried round bottom flask 
under argon was dissolved 0.50 g of 1,2-dibromo-5-fluoro-3-nitrobenzene 3.18.a (3.35 
mmol) in THF (20 mL) and cooled to -40 °C. To this stirring solution was added vinyl 
magnesium bromide (1 M, 11.7 mmol) at -40 °C. The reaction was stirred at -40 °C for 1 h, 
then quenched with aqueous NH4Cl (100 mL) and allowed to warm to rt. The mixture was 
extracted with diethyl ether (3 x 50 mL), the combined organic layers washed with water (1 x 
50 mL), brine (25 mL) and dried over anhydrous magnesium sulfate. The solution was 
filtered and concentrated under reduced pressure. The crude mixture was purified via column 
chromatography on silica gel using 10% ethyl acetate in hexanes to give 150  mg of 6,7-
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dibromo-4-fluoro-1H-indole 3.19.a in 31% as off-white solid, mp = 84-86 °C. 1H-NMR: 
bs, 1 H), 7.23 (m, 1 H), 7.10 (d, J = 9.4 Hz, 1 H), 6.71 (dd, J = 2.1, 3.3 Hz, 1 H); 
13C-NMR:  156.26, 153.75, 125.05, 116.38, 110.43, 110.19, 102.12, 100.58. 
 
 
6,7-dibromo-4-fluoro-1-methyl-1H-indole (3.20.a): In a 100 mL flame dried round bottom 
flask under argon was added 125 mg (0.43 mmol) of 6,7-dibromo-4-fluoro-1H-indole 3.19.a. 
This was dissolved in 10 mL of dry THF and to this solution was added 21 mg (0.86 mmol) 
of dry sodium hydride. The solution was stirred at room temperature for 30 min, and then 55 
µL (0.86 mmol) of iodomethane was added via syringe. The resulting solution was stirred for 
1 h, and then quenched by dropwise addition of aq. NH4Cl (20 mL). The aqueous mixture 
was extracted with diethyl ether (3 x 25 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue 
was purified via flash column chromatography on silica gel using 20% TBME in hexanes as 
eluent to give 268 mg (86%) of 6,7-dibromo-4-fluoro-1-methyl-1H-indole 3.20.a as a brown 
solid, mp = 69-71 °C. RdJHzdJHz
dJHzs13C-NMR:  156.03, 153.54, 132.30, 119.43(d, J = 
23.4 Hz), 118.17(d, J = 9.5 Hz), 110.10 (d, J = 23.4 Hz), 101.73, 97.37, 37.59. 
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4-iodo-2-nitroaniline (3.16.b): See 4-fluoro-2-nitroaniline (3.15.a). A yellow/brown solid, 
mp = 120-122 °C whose physical properties were identical to that of the commercially 
available compound. 
 
2-bromo-4-iodo-6-nitroaniline (3.17.b): See 2-bromo-4-fluoro-6-nitroaniline (3.17.a). A 
yellow solid, mp = 101-104 °C whose physical properties were identical to that of the 
commercially available compound. 
 
1,2-dibromo-5-iodo-3-nitrobenzene (3.18.b): See 1,2-dibromo-5-fluoro-3-nitrobenzene 
(3.18.a). A brown solid, mp = 82-84 °C. 1H-NMR:  8.63 (d, J = 2.5 Hz, 1 H); 8.45 (d, J = 
2.5 Hz, 1 H). 
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6,7-dibromo-4-iodo-1H-indole (3.19.b): See 6,7-dibromo-4-fluoro-1H-indole (3.19.a). 
Purple solid, mp = 91-93 °C. 1H-NMR:  8.50 (bs, 1 H); 7.55 (s, 1 H); 7.30 (dd, J = 2.5, 3.3 
Hz, 1 H); 6.66 (dd, J = 2.3, 3.3 Hz, 1 H); 13C-NMR:  135.36, 128.69, 126.69, 125.76, 
117.16, 114.08, 106.46, 104.70. 
 
 
6,7-dibromo-4-iodo-1-methyl-1H-indole (3.20.b): See 6,7-dibromo-4-fluoro-1-methyl-1H-
indole (3.20.a). A purple amorphous solid. 1H-NMR: s, 1 H); d, J = 3.3 Hz, 
1H);d, J  =  3.3 Hz, 1H);s, 1H); 13C-NMR:  134.07, 133.00, 130.56, 126.68, 
119.11, 114.33, 106.10, 101.94, 37.98. 
 
4,6,7-tribromo-1-methyl-1H-indole (3.20.c): See Ref. Thorton, P. D., Brown, N., Hill, D., 
Neuenswander, B., Lushington, G. H., Santini, C., Buszek, K. R. ACS Combi. Sci. 2011, 13, 
443. 
 
6,7-dibromo-4-ethyl-1-methyl-1H-indole (3.20.d): See 6,7-dibromo-4-fluoro-1-methyl-1H-
indole (3.20.a). Yield. 0.14 g (89%). Yellow oil. 1H-NMR: s, 1 H); 6.96 (d, J = 3.1 
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Hz, 1 H); 6.44 (d, J = 3.1 Hz, 1 H); 4.14 (s, 1 H); 2.83 (q, J = 7.6 Hz, 2 H). 1.31 (t, J = 7.6 
Hz, 3 H); 13C-NMR:  136.85, 132.05, 131.79, 129.37, 123.10, 119.44, 103.81, 99.39, 37.71, 
25.51, 14.35. 
 
4,6,7-tribromo-3-phenyl-1H-indole (3.24): See 6,7-dibromo-3-(4-methoxyphenyl)-1H-
indole (3.14.b): Yellow oil. 1H-NMR:  bs, 1 H); 7.56 (s, 1 H); 7.47-7.43 (m, 2 H); 
7.42-7.37 (m, 3 H); 7.23 (m, 1 H); 13C-NMR:  136.18, 133.54, 131.35, 128.34, 127.38, 
127.15, 125.36, 124.36, 121.37, 117.41, 113.96, 106.84 
 
 
4,6,7-tribromo-1-methyl-3-phenyl-1H-indole (3.25): See 6,7-dibromo-4-fluoro-1-methyl-
1H-indole (3.20.a). 1H-NMR: s, 1 H); m, 5 H);s, 1 H);s, 3 
H); 13C-NMR:  134.75, 133.69, 133.06, 131.45, 130.03, 128.41, 127.22, 126.97, 119.46, 
118.12, 114.01, 106.26, 38.22. 
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9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): A flame dried 50 mL round bottom flask was charged with 10 mL of dry toluene, 
50 mg of 6,7-dibromo-3-(4-methoxyphenyl)-1-methyl-1H-indole (0.13 mmol) and 90 µL 
(0.65 mmol) of 2-tert-butyl furan under an atmosphere of argon, and the resulting mixture 
was cooled to -78 oC. To this cold solution was added 100 µL (2.6 M, 0.26 mmol) of n-
butyllithium in toluene dropwise, and the solution was stirred at -78 oC for 30 min. The cold 
bath was removed and the solution was allowed to warm slowly to room temperature over 1 
h. The reaction was quenched with aq. NH4Cl (10 mL). The aqueous layer was extracted with 
diethyl ether (3 x 25 mL). The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue was 
purified via flash column chromatography on silica gel using 10% CH2Cl2 in hexanes as 
eluent to give 34 mg (76%) of 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-
6,9-epoxybenzo[g]indole as an off-white solid, mp = 133-135 °C; 1H-NMR: m, 
4 H), dd, J = 2.2, 5.5 Hz, 2 H),d, J = 5.5 Hz, 1 H),m, 1 H),d, J = 
2.2 Hz, 1 H),d, J = 1.8 Hz, 1 H),s, 3 H),s, 3 H), 1.47 (s, 9 H); 13C-NMR:  
158.11, 148.32, 146.01, 142.62, 134.61, 134.32, 130.41, 129.31, 129.10, 127.57, 117.58, 
116.64, 114.08, 113.52, 104.66, 81.84, 55.31, 39.71, 33.39, 29.46. 
HRMS (EI): m/z calcd for C24H25NO: 359.1887; found: 359.1880. 
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9-(tert-Butyl)-3-(4-fluorophenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.3): See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo 
[g]indole (3.27.2): Yield: 21 mg (42%); pale yellow oil. 1H NMR: δ = 7.53–7.47 (m, 3 H), 
7.19–7.11 (m, 4 H), 7.07 (d, J = 5.6 Hz, 1 H), 7.00 (s, 1 H), 5.75 (d, J = 1.8 Hz, 1 H), 4.01 (s, 
3 H), 1.48 (s, 9 H); 13C NMR: δ = 162.73, 160.30, 148.58, 146.04, 142.59, 134.56 (d, J = 5.9 
Hz), 131.08 (d, J = 3.7 Hz), 130.74, 129.42 (d, J = 8.1 Hz), 129.044, 116.98, 116.43, 115.48 
(d, J = 21.4 Hz), 113.72, 104.71, 81.83, 39.73, 33.39, 29.47. 
HRMS (EI): m/z calcd for C23H22FNO: 347.1687; found: 347.1680. 
6-(tert-Butyl)-3-(4-fluorophenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole  
(3.28.3): See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo 
[g]indole (3.27.2): Yield: 3 mg (3%); green oil. 1H NMR: δ = 8.04 (d, J = 8.2 Hz, 1 H), 7.82 
(d, J = 8.2 Hz, 1 H), 7.56 (m, 3 H), 7.32 (m, 1 H), 7.22-7.14 (m, 3 H), 6.42 (d, J = 9.4 Hz, 1 
H), 3.89 (s, 3 H), 1.35 (s, 9 H): 13C NMR: δ = 162.54, 149.22, 145.10, 142.11, 136.63, 
136.50, 131.11, 130.32, 127.65, 126.64, 126.30, 117.88, 117.86, 116.10, 104.89, 80.71, 
37.02, 37.11, 26.67. 
HRMS (EI): m/z calcd for C23H22FNO: 347.1687; found: 347.1685. 
 
 
3-Benzyl-9-(tert-butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.27.4): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 48 mg (53%); pink oil. 1H NMR: δ = 7.28 (m, 5 H), 7.17 (d, J = 7.4 Hz, 1 
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H), 7.12 (dd, J = 1.9, 5.9 Hz, 1 H), 7.07 (d, J = 7.4 Hz, 1 H), 7.01 (d, J = 5.9 Hz, 1 H), 6.54 
(s, 1 H), 5.69 (d, J = 2.0 Hz, 1 H), 4.01 (s, 2 H), 3.86 (s, 3 H), 1.43 (s, 9 H): 13C NMR: δ = 
148.07, 145.92, 142.56, 140.67, 134.62, 133.95, 131.53, 130.72, 128.70, 128.30, 125.88, 
115.92, 115.39, 112.83, 104.49, 81.89, 39.49, 33.34, 31.45, 29.44. 
HRMS (EI): m/z calcd for C24H25NO: 343.1938; found: 343.1944. 
3-Benzyl-6-(tert-butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.28.4): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 5 mg (6%); pink oil. 1H NMR: δ = 7.26 (m, 5 H), 7.09 (m, 4 H), 6.56 (s, 1 
H), 6.20 (d, J = 1.6 Hz, 1 H), 4.02 (s, 2 H), 3.83 (s, 3 H), 1.32 (s, 9 H): 13C NMR: δ = 
144.54, 144.27, 143.85, 141.13, 134.28, 132.01, 128.68, 128.41, 128.30, 127.60, 125.81, 
114.65, 114.52, 114.15, 99.97, 79.86, 34.68, 32.55, 31.58, 26.79. 
HRMS (EI): m/z calcd for C24H25NO: 343.1938; found: 343.1937. 
 
 
9-(tert-Butyl)-3-ethyl-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.27.5): See 9-
(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 53 mg (55%); yellow oil. 1H NMR: δ = 7.30 (d, J = 7.4 Hz, 1 H), 7.19 (m, 2 
H), 7.10 (d, J = 5.5 Hz, 1 H), 6.75 (s, 1 H), 5.79 (d, J = 1.5 Hz, 1 H), 3.94 (s, 3 H), 2.78 (q, J 
= 7.8 Hz, 2 H), 1.53 (s, 9 H), 1.38 (t, J = 7.8 Hz, 3H): 13C NMR: δ = 147.83, 145.80, 
142.62, 134.66, 133.93, 130.75, 129.74, 118.16, 115.55, 112.66, 104.41, 81.83, 39.41, 33.33, 
29.43, 18.14, 13.94. 
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HRMS (EI): m/z calcd for C19H23NO: 281.1781; found: 281.1788. 
6-(tert-Butyl)-3-ethyl-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.28.5): See 9-
(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 9 mg (9%); yellow oil. 1H NMR: δ = 7.29 (d, J = 7.9 Hz, 1 H), 7.18 (d, J = 
7.9 Hz, 1 H), 7.08 (m, 2 H), 6.71 (s, 1 H), 6.21 (d, J = 1.6 Hz, 1 H), 3.84 (s, 3 H), 2.71 (q, J = 
7.5 Hz, 2 H), 1.34 (s, 9 H), 1.28 (t, J = 7.5 Hz, 3 H): 13C NMR: δ = 144.53, 144.31, 143.67, 
134.28, 131.94, 127.67, 126.91, 117.49, 114.45, 113.84, 100.02, 79.82, 34.55, 32.58, 26.81, 
18.30, 14.50. 
HRMS (EI): m/z calcd for C19H23NO: 281.1781; found: 281.1786. 
 
 
9-(tert-Butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.27.6): See 9-(tert-
butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.27.2): 
Yield: 39 mg (45%); yellow oil. 1H NMR: δ = 7.28 (d, J = 2.9 Hz, 1 H), 7.15 (dd, J = 1.8, 
5.6 Hz, 1 H), 7.11 (d, J = 7.3 Hz, 1 H), 7.04 (d, J = 5.6 Hz, 1 H), 6.91 (d, J = 3.1 Hz, 1 H), 
6.48 (d, J = 3.1 Hz, 1 H), 5.71 (d, J = 1.5 Hz, 1 H), 3.97 (s, 3 H), 1.46 (s, 9 H): 13C NMR 
(CD3CN): δ = 149.54, 147.00, 143.74, 135.41, 134.99, 134.34, 118.44, 118.38, 114.18, 
105.59, 103.16, 82.65, 40.24, 34.17, 29.80. 
HRMS (EI): m/z calcd for C17H19NO: 253.1468; found: 253.1466. 
6-(tert-Butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.28.6): See 9-(tert-
butyl)-3-(4 methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.27.2): 
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Yield: 14 mg (16%); yellow oil. 1H NMR: δ = 7.31 (d, J = 7.9 Hz, 1 H), 7.21 (d, J = 7.9 Hz, 
1 H), 7.09 (d, J = 5.6 Hz, 1 H), 7.07 (dd, J = 1.8, 5.6 Hz, 1 H), 6.93 (d, J = 3.2 Hz, 1 H), 6.39 
(d, J = 3.2 Hz, 1 H), 6.22 (d, J = 1.8 Hz, 1 H), 3.90 (s, 3 H), 1.34 (s, 9 H): 13C NMR: δ = 
144.53, 144.41, 143.80, 134.40, 131.52, 130.42, 128.11, 116.30, 114.65, 101.17, 100.05, 
79.89, 34.92, 32.56, 26.79. 
HRMS (EI): m/z calcd for C17H19NO: 253.1468; found: 253.1470. 
 
 
9-(tert-Butyl)-1-methyl-2-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.30.2): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 37 mg (55%); pale yellow foam. 1H NMR: δ = 7.56–7.08 (m, 9 H), 6.62 (s, 
1 H), 5.71 (d, J = 1.6 Hz, 3 H), 3.56 (s, 3 H), 1.45 (s, 9 H): 13C NMR: δ = 147.97, 147.46, 
146.19, 142.01, 139.72, 135.66, 132.61, 130.96, 128.80, 128.55, 127.91, 117.12, 114.33, 
104.68, 103.79, 81.45, 39.55, 33.97, 29.14. 
HRMS (EI): m/z calcd for C23H23NO: 329.1781; found: 329.1788. 
6-(tert-Butyl)-1-methyl-2-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.31.2): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 4 mg (6%); pale yellow foam. 1H NMR: δ = 8.09–7.22 (m, 9 H), 6.49 (s, 1 
H), 6.31 (d, J = 0.8 Hz, 1 H), 3.84 (s, 3 H), 1.36 (s, 9 H): 13C NMR: δ = 147.87, 144.54, 
144.32, 142.94, 136.13, 128.79, 128.75, 128.45, 127.44, 125.63, 121.34, 115.92, 115.13, 
102.09, 100.40, 80.07, 39.13, 33.10, 32.14, 39.55. 
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HRMS (EI): m/z calcd for C23H23NO: 329.1781; found: 329.1789. 
 
 
9-(tert-Butyl)-1-methyl-2,3-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.30.3): 
See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 54 mg (53%); yellow foam. 1H NMR: δ = 7.33–7.27 (m, 11 H), 7.15 (m, 2 
H), 7.07 (d, J = 5.5 Hz, 1 H), 5.71 (d, J = 1.6, 1 H), 3.53 (s, 3 H), 1.46 (s, 9 H): 13C NMR: δ 
= 148.43, 146.22, 142.95, 142.18, 138.24, 135.69, 135.07, 131.80, 130.94, 130.74, 130.02, 
128.29, 128.21, 127.80, 125.98, 117.78, 116.29, 114.28, 104.03, 81.46, 39.25, 34.04, 29.28. 
HRMS (EI): m/z calcd for C29H27NO: 405.2094; found: 405.2099. 
6-(tert-Butyl)-1-methyl-2,3-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.31.3): 
See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 9 mg (9%); yellow foam. 1H NMR: δ = 7.31 (m, 2 H), 7.23–7.17 (m, 10 H), 
7.09 (m, 2 H), 6.32 (d, J = 0.9 Hz, 1 H), 3.77 (s, 3 H), 1.37 (s, 9 H): 13C NMR: δ = 144.70, 
146.56, 142.32, 139.02, 135.14, 134.67, 132.36, 131.54, 131.10, 129.84, 128.38, 128.11, 
126.51, 125.56, 117.84, 115.29, 115.15, 100.33, 100.06, 80.25, 32.83, 32.56, 29.66. 
HRMS (EI): m/z calcd for C29H27NO: 405.2094; found: 405.2090. 
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4-bromo-9-(tert-butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.32.1): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yellow oil. Yield: 37 mg (59%). 1H-NMR: s, 1H); dd, J = 1.8, 5.5 Hz, 
1 H),d, J = 5.5 Hz, 1 H),d, J =  3.5 Hz, 1 H),d, J = 3.5 Hz, 1 
H),d, J = 1.8 Hz, 1 H),s, 3H),s, 9H); 13C-NMR:  149.63, 145.81, 
142.66, 133.84, 133.42, 130.60, 116.63, 111.13, 104.99, 104.69, 103.02, 81.57, 39.80, 33.26, 
29.38. 
HRMS (EI): m/z calcd for C17H18BrNO: 331.0572; found: 331.0575. 
4-bromo-6-(tert-butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.34.1): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yellow oil. Yield: 11 mg (17%); 1H-NMR: s, 1H), m, 2 H),d, J 
= 3.1 Hz, 1 H),d, J = 3.1 Hz, 1 H),m, 1 H),s, 3 H),s, 9 H); 13C-
NMR:  145.60, 144.61, 144.23, 134.17, 131.00, 128.17, 122.95, 117.93, 109.88, 101.66, 
100.07, 79.77, 35.14, 29.72, 26.73. 
HRMS (EI): m/z calcd for C17H18BrNO: 331.0572; found: 331.0577. 
 
 
4-bromo-9-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.33.2): See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo 
g]indole (3.27.2): Off-white solid. Yield: 46 mg (62%). mp: 154-156 °C. 1H-NMR: 
m, 3 H), m, 3 H),s, 1 H),dd, J  = 1.8, 2.3 Hz, 1 H),d, J = 5.5 
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Hz, 1 H),d, J = 1.8 Hz, 1H),s, 3 H),s, 9 H); 13C-NMR:  149.47, 145.78, 
142.54, 135.46, 135.05, 134.22, 133.76, 131.41, 127.05, 126.62, 126.46, 119.06, 118.69, 
110.77, 104.94, 81.32, 39.71, 33.60, 29.52. 
HRMS (EI): m/z calcd for C23H22BrNO: 407.0886; found: 407.0890. 
4-bromo-6-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.34.2): See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo 
[g]indole (3.27.2): Off-white solid. Yield: 10 mg (14%).  Mp: 185-187 °C. 1H-NMR: 
s, 1 H), m, 2 H),m, 3 H),m, 2 H),s, 1 H),d, J = 1.8 Hz, 
1 H),s, 3 H),s, 9 H); 13C-NMR:  145.71, 144.66, 144.16, 134.71, 134.42, 
132.34, 131.39, 131.09, 127.12, 126.52, 124.03, 119.96, 118.22, 109.74, 100.05, 79.99, 
35.13, 32.52, 26.72. 
HRMS (EI): m/z calcd for C23H22BrNO: 407.0886; found: 407.0889. 
 
 
5-Bromo-9-(tert-butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.36.1): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 34 mg (39%); yellow oil. 1H NMR: δ = 7.36 (s, 1 H), 7.19 (dd, J = 1.8, 5.5 
Hz, 1 H), 7.04 (d, J = 5.5 Hz, 1 H), 6.91 (d, J = 3.3 Hz, 1 H), 6.39 (d, J = 3.3 Hz, 1 H), 5.91 
(d, J = 1.9 Hz, 1 H), 3.94 (s, 3 H), 1.43 (s, 9 H): 13C NMR: δ = 147.09, 145.69, 142.95, 
139.86, 136.93, 134.28, 133.31, 120.37, 107.27, 105.91, 102.05, 82.44, 39.77, 33.43, 29.41. 
HRMS (EI): m/z calcd for C17H18BrNO: 331.0572; found: 331.0580. 
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5-Bromo-6-(tert-butyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.37.1): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yield: 25 mg (29%); brown oil. 1H NMR: δ = 7.43 (s, 1 H), 7.04 (m, 2 H), 6.94 (d, 
J = 3.1, 1 H), 6.31 (d, J = 3.3 Hz, 1 H), 6.24 (d, J = 1.6 Hz, 1 H), 3.88 (s, 3 H), 1.46 (s, 9 H): 
13C NMR: δ = 144.38, 144.15, 143.61, 137.69, 132.50, 130.82, 130.59, 122.26, 106.96, 
103.28, 100.11, 79.15, 35.23, 32.65, 29.81. 
HRMS (EI): m/z calcd for C17H18BrNO: 331.0572; found: 331.0579. 
 
 
5-Bromo-9-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.36.2): See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-
epoxybenzo[g]indole (3.27.2): Yield: 24 mg (36%); yellow oil. 1H NMR: δ = 7.62 (s, 1 H), 
7.50 (m, 2 H), 7.42 (m, 2 H), 7.29 (m, 1 H), 7.18 (dd, J = 1.8, 5.5 Hz, 1 H), 7.06 (d, J = 5.5 
Hz, 1 H), 7.01 (s, 1 H), 5.93 (d, J = 1.8 Hz, 1 H), 3.99 (s, 3 H), δ 1.45 (s, 9 H): 13C NMR: 
δ = 145.34, 144.67, 138.60, 136.02, 135.95, 133.47, 128.50, 128.30, 127.07, 126.30, 
123.65, 118.85, 117.01, 114.27, 100.76, 79.70, 39.37, 36.75, 26.67. 
HRMS (EI): m/z calcd for C23H22BrNO: 407.0886; found: 407.0895. 
5-Bromo-6-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.37.2): See 9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9- 
epoxybenzo[g]indole (3.27.2): Yield: 17 mg (26%); brown oil. 1H NMR: δ = 7.66 (s, 1 H), 
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7.48 (m, 2 H), 7.35 (m, 2 H), 7.21 (m, 1 H), 7.04 (s, 1 H), 6.99 (m, 2 H), 6.21 (d, J = 1.8 Hz, 
1 H), 3.86 (s, 3 H), 1.48 (s, 9 H): 13C NMR: δ = 146.88, 145.43, 136.78, 136.73, 134.62, 
133.90, 128.50, 128.12, 127.10, 126.94, 126.30, 118.78, 116.33, 100.41, 100.34, 80.11, 
37.85, 37.07, 26.82. 
HRMS (EI): m/z calcd for C23H22BrNO: 407.0886; found: 407.0890. 
 
 
9-(tert-butyl)-4-fluoro-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.39.1): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yellow oil. Yield: 39 mg (49%). 1H-NMR: dd, J = 1.7, 1.7 Hz, 1 H), 
d, J = 5.5 Hz, 1 H),d, J = 3.5 Hz, 1 H),d, J = 8.0 Hz, 1 H),d, J = 3.3 
Hz, 1 H),d, J = 1.7 Hz, 1 H),s, 3 H),s, 9 H); 13C-NMR:  154.55, 152.10, 
149.95, 145.66, 143.17, 132.36, 129.73, 104.62, 100.38, 99.85, 98.15, 81.86, 39.61, 33.20, 
29.39. 
HRMS (EI): m/z calcd for C17H18FNO: 271.1373; found: 271.1380. 
6-(tert-butyl)-4-fluoro-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.40.1): See 
9-(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Pale yellow solid. Yield. 17 mg (22%), mp = 118-120 °C. 1H-NMR: d, J  =  
1.2 Hz, 1 H), d, J = 0.6 Hz, 1 H),d, J = 0.6 Hz, 1 H),d, J = 3.1 Hz, 1 
H),d, J = 3.1 Hz, 1 H),d, J = 0.8 Hz, 1 H),s, 3 H),s, 9 H); 13C-
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NMR:  154.17, 151.73, 145.55, 145.04, 144.18, 133.26, 130.02, 115.80, 101.60, 100.31, 
97.35, 79.82, 34.99, 32.50, 26.67. 
HRMS (EI): m/z calcd for C17H18FNO: 271.1373; found: 271.1372. 
 
 
9-(tert-butyl)-4-iodo-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.38.3): See 9-
(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Purple solid. Yield: 50 mg (61%), mp = 99-101 °C.  1H-NMR: s, 1 H), 
dd, J = 1.8, 5.5 Hz, 1 H),d, J = 5.5 Hz, 1 H),d, J = 3.3 Hz, 1 H),d, J 
= 3.3 Hz, 1 H),d, J = 1.8 Hz, 1 H),s, 3 H),s, 9 H); 13C-NMR: 149.61, 
145.80, 142.65, 133.89, 133.83, 133.42, 130.58, 116.61, 111.12, 104.68, 102.99, 81.55, 
39.80, 33.25, 29.73. 
HRMS (EI): m/z calcd for C17H18INO: 379.0434; found: 379.0444. 
6-(tert-butyl)-4-iodo-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.40.3): See 9-
(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Purple solid. Yield: 9 mg (4%), mp =136-138 °C. 1H-NMR: d, 1 H), 
m, 2 H),d, J = 3.3 Hz, 1 H),d, J = 3.3 Hz, 1 H),m, 1H),s, 3 
H),s, 9 H); 13C-NMR:  145.58, 144.61, 144.21, 134.15, 131.46, 131.01, 128.15, 
118.82, 117.91, 109.87, 101.65, 79.76, 35.13, 29.69, 26.72. 
HRMS (EI): m/z calcd for C17H18INO: 379.0434; found: 379.0450. 
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9-(tert-butyl)-4-ethyl-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.39.4): See 9-
(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Yellow oil. Yield: 50 mg (58%). 1H-NMR: dd, J = 1.8, 1.8 Hz, 1 H), 
d, J = 5.7 Hz, 1 H),s, 1H),d, J = 3.5 Hz, 1 H),d, J = 3.3 Hz, 1 
H),d, J = 1.8 Hz, 1 H),s, 3 H),q, J = 7.6 Hz, 2 H), 1.47 (s, 9 H), t, J = 
7.6 Hz, 3 H); 13C-NMR:  148.39, 145.76, 142.84, 133.67, 133.23, 132.17, 131.35, 129.41, 
112.45, 104.54, 100.65, 81.96, 39.64, 33.27, 29.40, 25.67, 14.51. 
HRMS (EI): m/z calcd for C19H23NO: 281.1781; found: 281.1787. 
6-(tert-butyl)-4-ethyl-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (3.40.4): See 9-
(tert-butyl)-3-(4-methoxyphenyl)-1-methyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 
(3.27.2): Dark yellow oil. Yield: 4 mg (5%). 1H-NMR: s, 1 H), m, 1 H),d, 
J = 3.3 Hz, 1 H),d, J = 3.3 Hz, 1 H),d, J = 1.6 Hz, 1 H),s, 3 H),q, J 
= 7.6 Hz, 2 H),s, 9 H),t, J =  7.6 Hz, 3 H); 13C-NMR:  144.79, 144.26, 132.35, 
132.02, 131.39, 129.63, 113.88, 105.00, 100.10, 99.60, 89.10, 79.90, 34.96, 32.58, 29.69, 
26.69, 15.19. 
HRMS (EI): m/z calcd for C19H23NO: 281.1781; found: 281.1783. 
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Novel tribromoindoles 
 
 
 
 
N-(m-tolyl)acetamide (4.23): In a 500 mL round bottom flask, 2.00 g (18.7 mmol) of 4.22 
was dissolved in 187 mL of 1,2-dichloroethane. To this was added 19.07 (18.7 mmol) of 
acetic anhydride and the mixture heated to 84 °C for 1 h. The reaction mixture was poured 
over ice and the biphasic mixture extracted with ethyl acetate (3 x 100 mL). The combined 
organic layer was dried over anhydrous magnesium sulfate and then filtered. The filtrate was 
concentrated under reduced pressure to obtain 2.62 g (94%) of 4.23 as a white solid, mp = 
65-66 °C. 1H-NMR (CDCl3) : bs, 1 H), s, 1 H),d, J = 7.8 Hz, 1 
H),t, J = 7.8 Hz, 15.6, 1 H),d, J = 7.8 Hz, 1 H),s, 3 H),s, 3 H); 13C-
NMR (CDCl3) :  168.8, 138.7, 137.9, 128.3, 125.0, 120.7, 117.1, 24.3, 21.3.  
 
 
N-(3-methyl-4-nitrophenyl)acetamide (4.24): In a 50 mL round bottom flask, 1.00 g (6.71 
mmol) of 4.23 was dissolved in 7.0 mL of conc. H2SO4 and stirred at 0 °C. To the stirring 
mixture was added a mixture of conc. H2SO4 (1.0 mL) and conc. HNO3 (0.3 mL) dropwise. 
The reaction mixture was stirred at 0 °C for 1 h and then poured over ice. The solid 
precipitate was filtered and dried under vacuum at 50 °C to obtain 0.98 g (75%) of 4.24 as a 
yellow solid, mp = 101-102 °C. 1H-NMR (CDCl3) : d, J = 8.9 Hz, 1 H), bs, 2 
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H),d, J = 2.2 Hz, 1 H),dd, J = 2.2, 8.9 Hz, 1 H),s, 3 H),s, 3 H); 
13C-NMR (CDCl3) :  168.6, 144.3, 142.2, 136.1, 126.6, 122.3, 116.9, 24.8, 21.3. 
 
 
 
 
3-methyl-4-nitroaniline (4.25): In a 500 mL round bottom flask, 2.62 g (17.3 mmol) of 4.24 
was dissolved in 175 mL of glyme. To this was added 5.3 mL of conc. HCl and the mixture 
heated to 85 °C for 3 h. The reaction mixture was poured neutralized with 1M NaOH and 
mixture extracted with ethyl acetate (3 x 100 mL). The combined organic layer was dried 
over anhydrous magnesium sulfate and then filtered. The filtrate was concentrated under 
reduced pressure to obtain 2.26 g (84%) of 4.25 as a yellow solid, mp = 132-133 °C. 1H-
NMR  (CDCl3): d, J = 8.9 Hz, 1 H), d, J = 2.7 Hz, 1 H),dd, J = 2.7, 8.9 
Hz, 1 H),bs, 2 H),s, 3 H); 13C-NMR (CDCl3) :  151.2, 140.00, 137.7, 128.2, 
116.8, 111.8, 22.1. 
 
 
2,6-dibromo-3-methyl-4-nitroaniline (4.26):  In 500 mL round bottom flask was dissolved 
2.26 g (14.8 mmol) 4.25 in 150 mL of methanol. To the vigorously stirred solution was 
carefully added 7.50 mL (44.5 mmol) concentrated aqueous HBr (47% wt/wt) followed by 
3.38 mL (29.7 mmol) 30% aqueous H2O2 dropwise over 15 minutes. The mixture was stirred 
at room temperature overnight. The mixture was poured into 1.0 L of 1 M NaOH and the 
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resulting suspension was filtered and washed with water until neutral. Dried under vacuum at 
50 °C gave 4.18 g (91%) of 4.26 as a yellow solid, mp = 123-124 °C. 1H-NMR (CDCl3): 
s, 1 H), bs, 2 H),s, 3 H); 13C-NMR (CDCl3) :  146.3, 140.7, 134.9, 
128.7, 111.7, 103.9, 21.1. 
 
 
1,2,3-tribromo-4-methyl-5-nitrobenzene (4.27): In a 500 mL round-bottom flask was 
dissolved 3.92 g (17.6 mmol) CuBr2 in 140 mL of dry CH3CN and heated to 60 °C. To the 
warm solution was added 2.57 mL (21.6 mmol) tert-butyl nitrite followed by portion wise 
addition of 4.18 g (13.5 mmol) of 4.26. The mixture was stirred at 60 °C for 1 h. The solution 
was cooled to room temperature and poured into 200 mL of 20% aqueous ammonia. The 
mixture was extracted with TBME (3 x 100 mL) and the combined organic layers were 
washed sequentially with 20% aqueous ammonia (100 mL), water (100 mL), brine (50 mL), 
and then dried over anhydrous magnesium sulfate. The solution was filtered and concentrated 
under reduced pressure to give 3.89 g (77%) of 4.27 as light brown solid, mp = 100-101 °C. 
1H-NMR (CDCl3): s, 1 H),s, 3 H); 13C-NMR (CDCl3):  149.7, 133.7, 133.4, 
131.2, 126.9, 123.16, 21.6. 
 
4,5,6-tribromo-1H-indole (4.28): In a 50 mL round bottom flask a mixture of 3.89 g (10.4 
mmol) 4.27 and 4.14 g (15.6 mmol) TPM was heated to 105 °C under vacuum (15 torr) with 
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vigorous stirring. After 3 h an aliquot of the mixture showed complete reaction by TLC (20% 
CH2Cl2 in hexane). Cooled to room temperature and passed through a plug of silica gel 
eluting with 50% TBME in hexanes and concentrated under reduced pressure to give the 
crude intermediate which was then suspended in 100 mL methanol in a 500 mL round 
bottom flask and heated to reflux. To the red solution was added 0.182 g (0.676 mmol) of 
FeCl3•6H2O and 0.412 g (34.3 mmol) activated carbon. The mixture was refluxed for 5 
minutes, and then 2.03 mL (41.6 mmol) NH2NH2•H2O was added via a syringe over 10 
minutes and refluxed for 1 h. The mixture was cooled to room temperature and filtered 
through a 1 cm pad of celite, washing with methanol. The filtrate was concentrated under 
reduced pressure to about 5 mL, then diluted with 1M HCl (100 mL), extracted with CH2Cl2 
(3 x 75 mL). The combined organic phases were washed with water (2 x 100 mL), brine (50 
mL), and dried over anhydrous magnesium sulfate. The solution was filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 1.91 g (52%) of 
4.29 as a white solid, mp = 110-111 °C. 1H-NMR (CDCl3): 8.34 (bs, 1 H, NH); 7.69 (s, 1 
H); 7.26 (dd, J = 3.3, 3.3 Hz, 1 H); 6.56 (dd, J = 3.3, 3.3 Hz, 1 H). 13C-NMR (CDCl3):  
134.5, 129.9, 126.3, 117.9, 117.6, 117.5, 115.1, 104.7.  
 
 
4,5,6-tribromo-1-methyl-1H-indole (4.30): In a 100 mL flame dried round bottom flask 
under argon was added 250 mg (0.71 mmol) of 4,5,6-tribromoindole 4.29. This was 
 97 
 
dissolved in 7.0 mL of dry THF and to this solution was added 35 mg (1.42 mmol) of dry 
sodium hydride. The solution was stirred at room temperature for 30 min, and then 92 µL 
(1.42 mmol) of iodomethane was added via syringe. The resulting solution was stirred for 1 
h, and then quenched by dropwise addition of aq. NH4Cl (20 mL). The aqueous mixture was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue 
was purified via flash column chromatography on silica gel using 10% TBME in hexanes as 
eluent to give 240 mg (92%) of 4,5,6-tribromo-1-methyl-1H-indole 4.30 as a white solid, mp 
= 97-98 °C. 1H-NMR (CDCl3): 
sdJHzdJHzs 13C-NMR 
(CDCl3):  135.6, 130.9, 130.2, 117.6, 117.3, 117.0, 113.5, 103.0, 33.3. 
 
 
4,6-dibromo-2-methyl-3-nitroaniline (4.31): In 500 mL round bottom flask was dissolved 
2.00 g (13.2 mmol) 4.31 in 130 mL of methanol. To the vigorously stirred solution was 
carefully added 6.70 mL (39.6 mmol) concentrated aqueous HBr (47% wt/wt) followed by 
3.00 mL (26.4 mmol) 30% aqueous H2O2 dropwise over 15 minutes. The mixture was stirred 
at room temperature overnight. The mixture was poured into 1.0 L of 1M NaOH and the 
resulting suspension was filtered and washed with water until neutral. Dried under vacuum at 
50 °C gave 3.72 g (91%) of 4.32 as an orange solid, mp = 98-99 °C. 1H-NMR (CDCl3): 
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s, 1 H), bs, 2 H),s, 3 H); 13C-NMR (CDCl3):  142.8, 135.8, 133.5, 115.6, 
110.2, 98.9, 13.7. 
 
1,2,5-tribromo-3-methyl-4-nitrobenzene (4.33): In a 500 mL round-bottom flask was 
dissolved 3.47 g (15.6 mmol) CuBr2 in 140 mL of dry CH3CN and heated to 60 °C. To the 
warm solution was added 2.28 mL (19.2 mmol) tert-butyl nitrite followed by portion wise 
addition of 3.72 g (12.0 mmol) of 4.32. The mixture was stirred at 60 °C for 1 h. The solution 
was cooled to room temperature and poured into 200 mL of 20% aqueous ammonia. The 
mixture was extracted with TBME (3 x 100 mL) and the combined organic layers were 
washed sequentially with 20% aqueous ammonia (100 mL), water (100 mL), brine (50 mL), 
and then dried over anhydrous magnesium sulfate. The solution was filtered and concentrated 
under reduced pressure to give 3.49 g (78%) of 4.33 as light brown solid, mp = 83-84 °C. 1H-
NMR (CDCl3): s, 1 H),s, 3 H); 13C-NMR (CDCl3):  134.8, 133.6, 133.2, 
128.1, 128.0, 111.6, 20.7. 
 
 
4,5,7-tribromo-1H-indole (4.35): In a 50 mL round bottom flask a mixture of 3.89 g (10.4 
mmol) 4.33 and 4.14 g (15.6 mmol) TPM was heated to 105 °C under vacuum (15 torr) with 
vigorous stirring. After 3 h an aliquot of the mixture showed complete reaction by TLC (20% 
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CH2Cl2 in hexane). Cooled to room temperature and passed through a plug of silica gel 
eluting with 50% TBME in hexanes and concentrated under reduced pressure to give the 
crude intermediate which was then suspended in 100 mL methanol in a 500 mL round 
bottom flask and heated to reflux. To the red solution was added 0.182 g (0.676 mmol) of 
FeCl3•6H2O and 0.412 g (34.3 mmol) activated carbon. The mixture was refluxed for 5 
minutes, and then 2.03 mL (41.6 mmol) NH2NH2•H2O was added via a syringe over 10 
minutes and refluxed for 1 h. The mixture was cooled to room temperature and filtered 
through a 1 cm pad of celite, washing with methanol. The filtrate was concentrated under 
reduced pressure to about 5 mL, then diluted with 1M HCl (100 mL), extracted with CH2Cl2 
(3 x 75 mL). The combined organic phases were washed with water (2 x 100 mL), brine (50 
mL), and dried over anhydrous magnesium sulfate. The solution was filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 2.06 g (56%) of 
4.35 as a white solid, mp = 131-132 °C. 1H-NMR (CDCl3): 8.48 (bs, 1 H, NH); 7.59 (s, 1 
H); 7.32 (dd, J = 3.3, 3.3 Hz, 1 H); 6.68 (dd, J = 3.3, 3.3 Hz, 1 H). 13C-NMR (CDCl3):  
133.2, 130.7, 127.8, 126.2, 116.0, 115.4, 105.6, 104.0.  
 
 
4,5,7-tribromo-1-methyl-1H-indole (4.36): In a 100 mL flame dried round bottom flask 
under argon was added 250 mg (0.71 mmol) of 4,5,6-tribromoindole 4.35. This was 
dissolved in 7.0 mL of dry THF and to this solution was added 35 mg (1.42 mmol) of dry 
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sodium hydride. The solution was stirred at room temperature for 30 min, and then 92 µL 
(1.42 mmol) of iodomethane was added via syringe. The resulting solution was stirred for 1 
h, and then quenched by dropwise addition of aq. NH4Cl (20 mL). The aqueous mixture was 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue 
was purified via flash column chromatography on silica gel using 10% TBME (tert-butyl 
methyl ether) in hexanes as eluent to give 245 mg (94%) of 4,5,7-tribromo-1-methyl-1H-
indole 4.36 as a white solid, mp = 123-124 °C. 1H-NMR (CDCl3): 
sdJHzdJHzs 13C-NMR 
(CDCl3):  133.2, 133.0, 131.7, 129.4, 116.2, 115.0, 103.4, 103.1, 37.0. 
 
 
5,6-dibromo-1-methyl-1H-indole (4.38): In a flame-dried 50 mL round bottom flask under 
argon was added a solution of 30 mg (0.08 mmol) 4.30 in 10 mL dry toluene and cooled to -
78 °C, then 64 µL (0.16 mmol) of a 2.5 M solution of n-butyllithium in hexanes was added 
dropwise via syringe over 15 min. The solution was stirred at -78 °C for 30 min and 
quenched with water (2 mL) then allowed to slowly warm to room temperature. The reaction 
the mixture was diluted with water (5 mL) and extracted with diethyl ether (3 x 10 mL). The 
combined organic phase was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 14 mg (62%) of 
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4.38 as a colorless oil. 1H-NMR (CDCl3):  7.44 (dd, J = 0.6, 1.5 Hz, 1 H); 7.42 (d, J = 1.5 
Hz, 1 H); 7.08 (d, J = 3.2 Hz, 1 H); 6.50 (dd, J = 0.6, 3.2 Hz, 1 H); 3.77 (s, 3 H); 13C-NMR 
(CDCl3):  137.3, 129.9, 128.2, 124.8, 115.2, 114.6, 111.6, 101.7, 33.3. 
 
 
4,5-dibromo-1-methyl-1H-indole (4.41): In a flame-dried 100 mL round bottom flask under 
argon was added a solution of 100 mg (0.26 mmol) 4.36 in 20 mL dry toluene and cooled to -
78 °C, then 208 µL (0.52 mmol) of a 2.5 M solution of n-butyllithium in hexanes was added 
dropwise via syringe over 15 min. The solution was stirred at -78 °C for 30 min and 
quenched with water (5 mL) then allowed to slowly warm to room temperature. The reaction 
the mixture was diluted with water (10 mL) and extracted with diethyl ether (3 x 20 mL). The 
combined organic phase was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 36 mg (48%) of 
4.41 as a yellow solid, mp = 61-62 °C. 1H-NMR (CDCl3):  7.39 (d, J = 8.8 Hz, 1 H); 7.12 
(dd, J = 0.7, 3.1 Hz, 1 H); 7.08 (d, J = 3.1 Hz, 1 H); 6.50 (dd, J = 0.7, 3.1 Hz, 1 H); 3.76 (s, 3 
H); 13C-NMR (CDCl3):  135.2, 130.8, 130.2, 125.7, 116.5, 114.9, 109.7, 102.5, 33.3. 
5,7-dibromo-1-methyl-1H-indole (4.42): Yellow wax, 9 mg (12%). 1H-NMR (CDCl3):  
7.65 (d, J = 1.6 Hz, 1 H); 7.45 (d, J = 1.6 Hz, 1 H); 6.97 (d, J = 3.1 Hz, 1 H); 6.38 (d, J = 3.1 
Hz, 1 H); 13C-NMR (CDCl3):  132.8, 132.6, 131.9, 128.3, 122.6, 112.19, 104.3, 100.7, 36.8. 
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5-bromo-3-methyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (4.44): In a flame-dried 25 
mL round bottom flask under argon was added a solution of 30 mg (0.08 mmol) 4.30 in 10 
mL dry toluene. To this was added 135 µL (1.6 mmol) of freshly cracked cyclopentadiene. 
The resulting solution was cooled to -78 °C, then 64 µL (0.16 mmol) of a 2.5 M solution of 
n-butyllithium in hexanes was added dropwise via syringe over 15 min. The solution was 
stirred at -78 °C for 30 min then allowed to slowly warm to room temperature. The reaction 
was then quenched by addition of saturated NH4Cl (10 mL). After stirring for 5 minutes, the 
mixture was diluted with water (10 mL) and extracted with diethyl ether (3 x 20 mL). The 
combined organic phase was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 14 mg (65%) of 
4.44 as a yellow oil. 1H-NMR (CDCl3):  7.05 (d, J = 0.8 Hz, 1 H); 6.99 (d, J = 3.3 Hz, 1 H); 
6.97 (dd, J = 3.3, 5.3 Hz, 1 H); 6.90 (dd, J = 3.3, 5.3 Hz, 1 H); 6.39 (dd, J = 0.8, 3.3 Hz); 
4.29 (m, 1 H); 4.22 (m, 1 H); 3.70 (s, 3 H); 2.38 (m, 2 H).   13C-NMR (CDCl3):  146.1, 
144.2, 142.9, 142.1, 136.9, 130.2, 123.9, 110.6, 106.8, 97.9, 71.7, 51.2, 50.2, 33.1. 
 
4-bromo-3-methyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (4.46): In a flame-dried 25 
mL round bottom flask under argon was added a solution of 30 mg (0.08 mmol) 4.36 in 10 
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mL dry toluene. To this was added 135 µL (1.6 mmol) of freshly cracked cyclopentadiene. 
The resulting solution was cooled to -78 °C, then 64 µL (0.16 mmol) of a 2.5 M solution of 
n-butyllithium in hexanes was added dropwise via syringe over 15 min. The solution was 
stirred at -78 °C for 30 min then allowed to slowly warm to room temperature. The reaction 
was then quenched by addition of saturated NH4Cl (10 mL). After stirring for 5 minutes, the 
mixture was diluted with water (10 mL) and extracted with diethyl ether (3 x 20 mL). The 
combined organic phase was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was then purified via column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 14 mg (64%) of 
4.46 as a colorless oil. 1H-NMR (CDCl3):  7.36 (s, 1 H); 6.97 (d, J = 3.1 Hz, 1 H); 6.90 (m, 
2 H); 6.42 (d, J = 3.1 Hz, 1 H); 4.20 (m, 1 H); 4.12 (s, 3 H); 3.98 (m, 1 H); 2.43 (m, 1 H); 
2.35 (m, 1 H).   13C-NMR (CDCl3):  144.3, 144.2, 143.7, 142.6, 132.7, 131.5, 127.5, 121.2, 
97.9, 97.8, 71.6, 50.3, 48.8, 37.0. 
 
 
5-bromo-6-(tert-butyl)-3-methyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (4.48): A 
flame dried 100 mL round bottom flask was charged with 10 mL of dry toluene, 100 mg of 
4.30 (0.27 mmol) and 377 µL (2.72 mmol) of 2-tert-butylfuran under an atmosphere of 
argon, and the resulting mixture was cooled to -78 oC. To this cold solution was added 228 
µL (2.6 M, 0.59 mmol) of n-butyllithium in toluene dropwise, and the solution was stirred at 
-78 oC for 30 min. The cold bath was removed and the solution was allowed to warm slowly 
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to room temperature over 1 h. The reaction was quenched with aq. NH4Cl (15 mL). The 
aqueous layer was extracted with diethyl ether (3 x 25 mL). The combined organic layers 
were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography on silica gel using 10% 
TBME in hexanes as eluent to give 32 mg (36%) of 4.48 as a colorless oil. 1H-NMR: 
s, 1 H), m, 3 H),dd, J = 0.9, 3.2 Hz, 1 H),d, J = 1.5 Hz, 1 
H),s, 3 H), 1.45 (s, 9 H); 13C-NMR:  148.2, 143.8, 142.4, 139.9, 133.4, 128.0, 127.4, 
108.0, 103.7, 102.5, 101.7, 81.2, 33.2, 32.5, 29.7. 
5-bromo-9-(tert-butyl)-3-methyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (4.49): 
Colorless oil, 25 mg (28%). 1H-NMR: d, J = 0.8 Hz, 1 H), dd, J = 0.9, 3.1 Hz, 2 
H),d, J = 3.1 Hz, 1 H),dd, J = 0.9, 3.1 Hz, 1 H),d, J = 1.5 Hz, 1 
H),s, 3 H), 1.46 (s, 9 H); 13C-NMR:  148.1, 144.4, 143.8, 140.4, 137.2, 131.3, 122.3, 
109.9, 108.8, 103.8, 97.7, 80.1, 33.1, 32.5, 29.7. 
 
 
4-bromo-9-(tert-butyl)-3-methyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (4.51): A 
flame dried 100 mL round bottom flask was charged with 10 mL of dry toluene, 100 mg of 
4.36 (0.27 mmol) and 377 µL (2.72 mmol) of 2-tert-butylfuran under an atmosphere of 
argon, and the resulting mixture was cooled to -78 oC. To this cold solution was added 228 
µL (2.6 M, 0.59 mmol) of n-butyllithium in toluene dropwise, and the solution was stirred at 
-78 oC for 30 min. The cold bath was removed and the solution was allowed to warm slowly 
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to room temperature over 1 h. The reaction was quenched with aq. NH4Cl (15 mL). The 
aqueous layer was extracted with diethyl ether (3 x 25 mL). The combined organic layers 
were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue was purified via flash column chromatography on silica gel using 10% 
TBME in hexanes as eluent to give 40 mg (44%) of 4.51 as a colorless oil. 1H-NMR: 
s, 1 H), dd, J = 1.8, 5.5 Hz, 1 H),dd, J = 3.3, 5.5 Hz, 2 H),d, J = 
3.3 Hz, 1 H),d, J = 1.8 Hz, 1 H), s, 3 H), 1.39 (s, 9 H); 13C-NMR:  146.2, 145.6, 
143.4, 141.9, 133.5, 132.5, 126.5, 119.6, 102.4, 100.8, 99.2, 81.6, 37.5, 31.9, 27.3. 
5-bromo-9-(tert-butyl)-3-methyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (4.52): 
Colorless oil, 20 mg (22%). 1H-NMR: s, 1 H), dd, J = 1.8, 5.5 Hz, 1 H),d, 
J = 5.5 Hz, 1 H),d, J = 3.1 Hz, 1 H),d, J = 3.1 Hz, 1 H),d, J = 1.8 Hz), 
s, 3 H), 1.32 (s, 9 H); 13C-NMR:  144.8, 144.3, 144.1, 142.0, 133.6, 131.7, 125.8, 
121.3, 100.4, 98.2, 97.9, 80.5, 37.0, 32.6, 26.7. 
 
 
3,5-dimethyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (4.53): In a 10 mL round bottom 
flask under argon was added 13.4 mg (0.015 mmol) of Pd2(dba)3 and 10.6 mg (0.037 mmol) 
of tBu3P.HBF4 followed by 50 mg (0.184 mmol) of 4.44 in 3.0 mL of THF. To this was 
added 0.55 mL (0.547 mmol) of dimethylzinc (1.0 M in PhMe) and the mixture stirred at 70 
°C for 3 h. After 3 h, the reaction mixture was cooled to room temperature and diluted with 
TBME (6.0 mL). The organic layer was washed with H2O (3 x 5 mL) followed by brine (1 x 
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5 mL). The resulting organic layer was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude product was purified via flash column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 28 mg (72%) of 
4.53 as a yellow solid, mp = 92-93 °C. 1H-NMR: d, J = 3.1 Hz, 1 H), m, 2 
H),s, 1 H),dd, J = 0.8, 3.1 Hz, 1 H),m, 1 H), m, 1 H), 3.71 (s, 3 H); 
2.51 (s, 3 H), 2.42 (m, 1 H), 2.33 (m, 1 H); 13C-NMR:  144.2, 143.7, 142.9, 141.5, 135.9, 
128.9, 125.4, 122.8, 104.4, 97.5, 71.3, 49.2, 48.2, 33.0, 19.1. 
 
 
5-ethyl-3-methyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (4.54): In a 10 mL round 
bottom flask under argon was added 13.4 mg (0.015 mmol) of Pd2(dba)3 and 10.6 mg (0.037 
mmol) of tBu3P.HBF4 followed by 50 mg (0.184 mmol) of 4.44 in 3.0 mL of THF. To this 
was added 0.55 mL (0.547 mmol) of diethylzinc (1.0 M in PhMe) and the mixture stirred at 
70 °C for 3 h. After 3 h, the reaction mixture was cooled to room temperature and diluted 
with TBME (6.0 mL). The organic layer was washed with H2O (3 x 5 mL) followed by brine 
(1 x 5 mL). The resulting organic layer was dried over anhydrous magnesium sulfate, filtered 
and concentrated under reduced pressure. The crude product was purified via flash column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 31 mg (75%) of 
4.54 as a yellow solid, mp = 87-88 °C. 1H-NMR: d, J = 3.1 Hz, 1 H), m, 2 
H),s, 1 H),dd, J = 0.8, 3.1 Hz, 1 H),m, 1 H), m, 1 H), 3.72 (s, 3 H), 
2.84 (q, J = 7.4, 14.8 Hz, 2 H), 2.41 (m, 1 H), 2.32 (m, 1 H), 1.29 (t, J = 7.4, 14.8 Hz, 3 H); 
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13C-NMR:  144.2, 143.8, 143.0, 141.0, 135.9, 132.2, 129.0, 122.9, 103.0, 97.5, 71.1, 49.1, 
48.2, 32.9, 26.9, 16.4. 
 
 
3,4-dimethyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (4.55): In a 10 mL round bottom 
flask under argon was added 13.4 mg (0.015 mmol) of Pd2(dba)3 and 10.6 mg (0.037 mmol) 
of tBu3P.HBF4 followed by 50 mg (0.184 mmol) of 4.46 in 3.0 mL of THF. To this was 
added 0.55 mL (0.547 mmol) of dimethylzinc (1.0 M in PhMe) and the mixture stirred at 70 
°C for 3 h. After 3 h, the reaction mixture was cooled to room temperature and diluted with 
TBME (6.0 mL). The organic layer was washed with H2O (3 x 5 mL) followed by brine (1 x 
5 mL). The resulting organic layer was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude product was purified via flash column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 32 mg (82%) of 
4.55 as a brown solid, mp = 115-116 °C. 1H-NMR: s, 1 H), d, J = 3.1 Hz, 1 
H),m, 2 H),d, J = 3.1 Hz, 1 H),m, 1 H), 4.03 (s, 3 H), m, 1 H), 2.75 
(s, 3 H), 2.43 (m, 1 H), 2.34 (m, 1 H); 13C-NMR:  144.4, 142.8, 142.6, 141.9, 133.9, 131.5, 
125.7, 119.2, 115.6, 97.6, 71.7, 50.5, 48.8, 36.8, 19.7. 
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4-ethyl-3-methyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (4.56): In a 10 mL round 
bottom flask under argon was added 13.4 mg (0.015 mmol) of Pd2(dba)3 and 10.6 mg (0.037 
mmol) of tBu3P.HBF4 followed by 50 mg (0.184 mmol) of 4.44 in 3.0 mL of THF. To this 
was added 0.55 mL (0.547 mmol) of diethylzinc (1.0 M in PhMe) and the mixture stirred at 
70 °C for 3 h. After 3 h, the reaction mixture was cooled to room temperature and diluted 
with TBME (6.0 mL). The organic layer was washed with H2O (3 x 5 mL) followed by brine 
(1 x 5 mL). The resulting organic layer was dried over anhydrous magnesium sulfate, filtered 
and concentrated under reduced pressure. The crude product was purified via flash column 
chromatography on silica gel using 10% TBME in hexanes as eluent to give 35 mg (86%) of 
4.56 as a pink solid, mp = 110-111 °C. 1H-NMR: s, 1 H), d, J = 3.1 Hz, 1 
H),m, 2 H),d, J = 3.1 Hz, 1 H),m, 1 H), 4.04 (m, 1 H), s, 3 H), 3.08 
(q, J = 7.4, 14.8 Hz, 2 H), 2.39 (m, 1 H), 2.32 (m, 1 H), 1.34 (t, J = 7.4, 14.8 Hz, 3 H); 13C-
NMR:  144.5, 142.8, 142.7, 141.6, 133.2, 131.7, 126.0, 122.4, 117.5, 97.7, 71.7, 50.6, 48.9, 
36.8, 25.5, 17.1. 
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Chapter 6.  
 
CONCLUSIONS 
 
 The total synthesis of (±)-cis-trikentrin B was successfully achieved by employing a 
strategic combination of 6,7-indole aryne cycloaddition methodology via a selective metal-
halogen exchange and elimination protocol, and Pd(0)-catalyzed  Stille cross-coupling 
reaction.  
 The effect of various substitution patterns at different positions on the indole on the 
regioselectivity of 6,7-indole aryne cycloadditions with 2-tert-butylfuran was investigated. 
The presence of substituents at the 3-position gave the greatest degree of regiocontrol. The 
effect of substitution at the 2-position on the indole ring still resulted in significant, albeit 
diminished regioselectivity. There was a marked decrease in the regiochemical distribution in 
presence of substitution at the C-4 and C-5 sites.  
 We have successfully synthesized two novel tribromoindoles namely, the 4,5,6- and 
4,5,7-tribromindoles using the Leimgruber-Batcho synthesis. The examination of the sites of 
metal-halogen exchange in these scaffolds revealed a preference for the C-7 position in the 
4,5,7-tribromoindole whereas, exclusively the C-4 site in the 4,5,6-tribromoindole. The 4,5-
indole aryne generated in the 4,5,6-tribromoindole exhibited virtually no regioselectivityity 
in cycloadditions with 2-tert-butylfuran . A slight enhancement in the regiochemical 
distribution was observed in the 4,5-indole aryne cycloadditions. Finally, we have 
demonstrated that the newly synthesized tribromoindoles can be utilized for the construction 
of novel benzannulated indole library compounds.  
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